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Abstract
In this thesis mathematical models describing the growth of a solid tumour in the pres-
ence of an immune response are presented. Specifically, attention is focused on the
interactions between cytotoxic T-lymphocytes (CTLs) and tumour cells in a small,
avascular multicellular tumour. At this stage of the disease the CTLs and the tumour
cells are considered to be in a state of dynamic equilibrium or cancer dormancy. The
precise biochemical and cellular mechanisms by which CTLs can control a cancer and
keep it in a dormant state are still not completely understood from a biological and
immunological point of view. The mathematical models focus on the spatio-temporal
dynamics of tumour cells, immune cells, chemokines and “chemo-repellors” in an im-
munogenic tumour. The CTLs and tumour cells are assumed to migrate and interact
with each other in such a way that lymphocyte-tumour cell complexes are formed.
These complexes result in either the death of the tumour cells (the normal situation)
or the inactivation of the lymphocytes and consequently the survival of the tumour
cells. In the latter case, we assume that each tumour cell which survives its “brief en-
counter” with the CTLs undergoes certain beneficial phenotypic changes. We explore
the dynamics of the model under these assumptions and show that the process of the
immuno-evasion can arise as a consequence of these encounters.
Our computational simulations suggest that the proposed mechanism is able to mimic
xxvii
various dynamics of immunoevasion during the lifespan of a mouse. We also high-
light the differential spatiotemporal contributions to evasion due, respectively, to: i)
a decrease in the probability pi of being lethally hit; ii) a decrease in the probability,
embedded in k+i , that a tumour cell is recognized by a CTL. In particular, our model
suggests that a decrease in the parameters pi is needed to produce evasion, which does
not occur in the case where pi remains constant at its baseline level inferred from the
experimental data. However, the role of the parameters k+i is important since it can
greatly accelerate the simulated process. Moreover, our computational simulations
also show that the proposed mechanism can also deeply affect the spatial patterning of
the tumour. In particular, our model suggests that to have a uniform invasion profile for
the tumour cells necessitates also having a decrease in the recognition rate, embedded
in the parameters k+i . These parameters also differentially shape the spatial distribution
of the various classes of tumour cells.
Also in this thesis, we discuss mathematical models of the interactions between a tu-
mour and both the innate and the cellular part of the adaptive immune system. We
have developed and formulated spatiotemporal models of the interactions between
macrophages, natural killer cells, cytotoxic T lymphocytes and tumour cells. In ad-
dition to presenting computational simulations of our ODE and PDE models, we in-
vestigate the linear stability analysis of steady states of the model and the effect of
the initial conditions on the behaviour of the ODE solution. We show that limit cycle
behaviour could be obtained by making some changes in the parameter values, which
gave us oscillations in the solution of the ODE and PDE systems. We observe that
there is a slowly damped oscillation in the behaviour of the tumour, natural killer and
CTL cells. Also we note that the solution converges to the second steady state where
the tumour size is small (dormant state).
xxviii
A model of cancer invasion and metastasis is also discussed in this thesis. This model
attempts to describe the interactions between cancer cells, urokinase plasminogen ac-
tivator (uPA), plasminogen activator inhibitor-1 (PAI-1), plasmin, extracellular matrix
(ECM) and the immune response. The mathematical model focuses on the effect of
the immune response on cancer invasion by assuming that there is some form of limit
cycle behaviour between the cancer cells and the effector cells. The work we present
in this chapter develops a mathematical model for tumour invasion with an immune
response using a continuum model in 1 and 2 space dimensions. This model consists
of a system of nonlinear partial differential equations and examines the effector cell re-
sponse the tumour invasion. This model consists of effector cells, tumour cells, ECM,
uPA, PAI-1, and plasmin. First, we set all spatial components of the model to zero and
consider only the reaction kinetics in order to compare between the behaviour of our
model and the original Chaplain and Lolas model (Chaplain and Lolas, 2005). The
spatially homogeneous simulation shows the behaviour of solutions have regular os-
cillations because there is a closed orbit. Second, we present the computational results
of the spatio-temporal model, and we note from these simulations that the tumour size
of our model is smaller than the tumour size of the Chaplain and Lolas model because
the immune cells are interacting with the tumour cells, and also the degradation of
ECM is less than that in the Chaplain and Lolas model. In addition, the number of
tumour cell clusters in our model is less than those in the Chaplain and Lolas model.
Also we found the tumour clusters of the mathematical model which was discussed in
this chapter to have the same range than the tumour clusters of the Chaplain and Lolas
model.
The final model presented in this thesis is a mathematical model of cancer cells and
effector cells which exhibit standing-wave behaviour between them. We show tha the
wave of invading cancer cells can be stopped by the wave of effector cells or ECM.
xxix
This model also focuses on the effect of the mutation of cancer cells to another sub-
population which is more malignant and which has the ability to invade the ECM or the
effector cells to occupy space. The numerical simulations discussed in this chapter are
essentially associated with an initial model of two equations representing the effector
cells and tumour cells, such that there is a standing wave between these species. We
note that the solution of the mathematical model is a travelling wave and also has a
standing wave solution (i.e. the wave of effector cells stops the wave of tumour cells
when they meet). This phenomenon occurs when the two diffusion coefficients are
the same. We calculate the wave speed to illustrate that the speed tends to zero when
the two waves meet - a positive speed of tumour cells refers to an invading tumour,
and a negative speed refers to the decreasing of effector cells. After this we modify
the model by adding an equation for a second cancer cell population T2, which is a
sub-population 2 of tumour cells. This is to reflect the fact that cancer is a progressive
disease, and as such it becomes more malignant as the cancer cells undergo successive
mutations. We show in this case how the new type of cancer cells start to invade the
effector cells after the failure of the first type. The third model discussed in this chapter
is arrived at by adding an ECM equation to the second model, and it explains how the
standing wave arise from two types of equations - the first one contains diffusion, and
the second one has no diffusion.
All the mathematical models in this thesis use numerical analysis of nonlinear partial
differential equations and computational simulations to obtain insight into the under-
lying biological systems. The systems of nonlinear partial differential equations were
numerically solved by a PDE solver in MATLAB for 1D and COMSOL for 2D. We
used the MATLAB PDE solver pdepe which uses the method described in Skeel and
Berzins (1990) for the spatial discretisation and the MATLAB routine ode15s for the
xxx
time integration.The numerical simulations demonstrate the existence of cell distribu-
tions that are quasi-stationary in time and heterogeneous in space. A linear stabil-
ity analysis of the underlying (spatially homogeneous) ordinary differential equation
(ODE) kinetics coupled with a numerical investigation of ODE system. Our approach
may lead to a deeper understanding of the phenomenon of interactions between cancer
cells and the immune response and may be helpful in the future development of more
effective anti-cancer vaccines.
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Chapter 1
Introduction
Tumours interact at different levels with the host organism, and in particular with the
host immune system. These interactions are complex, and therefore is important to
model them mathematically. Mathematical models can help us to better understand
these interactions. The immune system comprises two parts: the innate immune sys-
tem which protects the body from a large number of pathogens using defences that
are quickly mobilised and triggered by receptors that recognise a broad spectrum of
pathogens; and the adaptive immune system which develops specific cells to combat
infections by viral agents. The aim of this thesis is to characterise the main aspects of
the tumour-immune system interactions, by studying the interactions between tumours
and cytotoxic T lymphocytes (CTLs), macrophages, and natural killer cells.
In vivo experiments are crucial for the understanding of the interactions between the
immune system and tumours. However, they are usually very costly and can take
months for an experienced team to perform. They are also very complex to follow
since it is difficult to observe them without disrupting the ongoing process. So, in vivo
experiments can usefully be complemented by a mathematical and statistical approach.
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2Computer Science can help and enhance our understanding of the immune system-
tumour interactions by allowing us to simulate complex systems and behaviours that
cannot be observed directly. Computer models can simulate experiments lasting years
in real time in a far shorter time and give access to information which is normally
hidden during in vivo studies. The precision of these simulations depends on the model
used to represent the tumour-immune response interactions. In this thesis, we will
present four mathematical models, three for tumour-immune response interactions, and
one for a cancer invasion model. The three tumour-immune interactions models are: (i)
a model of tumour-CTLs interactions which develops the original work of Matzavinos
et al. (2004); (2) a model of macrophage-tumour interactions which develops the work
of (Owen and Sherratt, 1997, 1999), and (3) a model of natural killer cell-tumour
interactions which develops the work of de Pillis et al. (2005). The invasion model is
focussed on the role of the uPA plasminogen activation system and it’s role in cancer
invasion and develops work by Chaplain and Lolas (2005).
The remaining chapters are organised as follows.
Chapter 2 presents a biological overview of the immune system and its interactions
with cancer cells. The aim of this chapter is to give some basic information about the
main components of the immune system, especially macrophages, natural killer cells,
and CTLs, in addition to explaining the process of immune evasion.
Chapter 3 gives an overview of general reaction-diffusion equations, and explains
the important processes which can be applied to analyse mathematical models such
as linear stability analysis to determine the stability of the steady states, the non-
dimensionalisation of a model with its importance and steps, travelling wave analysis,
diffusion-driven instability to check the effect of adding a diffusion term to a system
3of ODEs, and limit cycle dynamics arising from Andronov-Hopf bifurcations.
In chapter 4 a review of the various mathematical models that have been developed
over the past few decades for the immune-response-tumour interactions is given. Also
some general mathematical models of cancer are reviewed.
A spatio-temporal model concerning the evasion of a tumour from the control of the
immune system is examined in chapter 5. In particular, we focus on the interactions
between CTLs and tumour cells in a small, avascular multicellular tumour, and we as-
sume that each tumour cell which survives its “brief encounter” with the CTLs under-
goes certain beneficial phenotypes changes. We show the process of immuno-evasion
can arise as a consequence of these encounters.
In chapter 6, we present a mathematical model of the interplay between a tumour and
both the innate and the cellular part of the adaptive immune system. We include in this
model three types of cell of the immune system: macrophages, natural killer cells and
CTLs.
In chapter 7, we present a mathematical model of cancer invasion with an immune
response. This model consists of a growing tumour and its interactions with urokinase
plasminogen activator, plasminogen activator inhibitor-1, plasmin, extracellular matrix
and an immune response.
Chapter 8, we describe a model of solid tumour development where competition for
space between the cancer cells, effector cells and ECM is important, and discuss the
possible dynamics of standing waves between the effector cells and the tumour cells.
We conclude the thesis with a final chapter concerning discussions and future work.
Chapter 2
Biological Background
In this chapter we review the biological background of cancer and the immune sys-
tem, and the interactions between them. We also describe the phenomenon of tumour
evasion from the immune response.
2.1 What is Cancer?
Cancer is not a single disease, but actually a collection of different diseases. It is
“a new growth of tissue resulting from a continuous proliferation of abnormal cells
that have the ability to invade and destroy other tissues” (King, 2000). In a now fa-
mous review paper, Hanahan and Weinberg attribute six key phenotypic differences,
or “hallmarks”, which distinguish cancer cells from healthy cells (Hanahan and Wein-
berg, 2000). These are:
• Self-sufficiency in growth signals,
• Insensitivity to growth-inhibitory (i.e. anti-growth) signals,
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5• Evasion of programmed cell death (apoptosis),
• Limitless replicative potential,
• Sustained angiogenesis,
• Tissue invasion and metastasis.
Recently Fang et al. (2008), also included low levels of oxygen:
• Hypoxia
Cancers are classified in two ways: by the type of tissue from which the cancer orig-
inated (histological type) and by the primary site, or the location in the body where
the cancer first developed (Alberts et al., 1994). Another term for cancer is “tumour”.
Tumour literally means “swelling” or mass. After carcinogenesis the development of
any cancer is a multi-step process. The initial mutations cause hyperplasia, where the
appearance of the cells remains normal but they reproduce too much. At this stage
the tumour is benign or non-invasive. Such tumours are not normally life-threatening.
They do not have a blood supply and therefore the size is limited, to a diameter of ap-
proximately 2mm, because all the nutrients they require to grow must diffuse in from
outside the tumour. Benign tumours are unable to destroy normal tissue but can com-
press it as they grow. Before becoming malignant, or invasive, the tumours go through
more mutations. Tumours may also induce the host’s blood vessel system to supply
them with the nutrients the tumour needs to grow, a process known as angiogenesis.
Malignant or invasive tumours are far less differentiated than benign ones. They also
have different adhesive properties. Benign cells are strongly homotypic which means
they stick to cells of their own kind. Malignant cells become heterotypic which means
that individual cells break away from the tumour and adhere to the surrounding con-
nective tissue. Malignant cells may invade the tissue and form secondary growths by a
multi-step process known as metastasis.
6Table 2.1: Cells of the immune system
Cell type Type of immunity
Neutrophils Innate
Eosinophils Innate
Basophils Innate
Mast cells Innate
Monocytes/macrophages Innate
Dendritic cells Innate
Natural killer cells Innate
Cytotoxic T lymphocytes Adaptive
Helper T lymphocytes Adaptive
B lymphocytes Adaptive
2.2 The Immune System Response
The Immune System is a collection of cells, tissues, and molecules that mediate re-
sistance to disease, specifically infectious disease. The coordinated reaction of these
cells and molecules to infectious microbes is the immune response. Immunology is
the study of the immune system and its response to invading pathogens (Abbas and
Lichtman, 2009). The immune system’s cellular components can be considered as me-
diators of either innate or adaptive immunity (see Table 2.1) (Todd and Spickett, 2005).
2.2.1 Innate and Adaptive Immunity
Innate immunity (also called natural or native immunity) refers to the fact that this type
of host defence is always present in healthy individuals, prepared to block the entry of
microbes and to rapidly eliminate microbes that do succeed in entering host tissue.
Adaptive immunity (also called specific or acquired immunity) is the type of host de-
fence that is stimulated by microbes that invade tissue, that is, it adapts to the presence
of microbial invaders (Abbas and Lichtman, 2009).
7The first line of defence in innate immunity is provided by epithelial barriers and by
specialised cells and natural antibiotics present in epithelia, all of which function to
block the entry of microbes. If microbes do breach the epithelia and enter the tissue
or circulation system, they are attacked by phagocytes, specialised lymphocytes called
natural killer cells, and several plasma proteins, including the proteins of the comple-
ment system. Innate immunity is rapidly activated in the early stages of an infection
and its defensive properties can limit the proliferation and spread of a pathogen within
the body. However, it is only moderately efficient in clearing infection, and its capa-
bilities remain the same on repeated exposure to the same microbe.
The resolution of an infection usually requires an additional adaptive immune response
by T-lymphocytes and B-lymphocytes (also referred to as T-cells and B-cells). The
adaptive immune response takes longer to activate than an innate immune response
but generates a more effective defence which improves upon repeated exposure to the
same microbe.
2.2.2 Cells of the Immune System
Both innate and adaptive immune responses depend upon the activities of white blood
cells or leukocyets. These cells all originate in the bone marrow, and many of them also
develop and mature there (Murphy et al., 2008). In this section we describe some types
of immune cells, which we will use in the mathematical models of the next chapters:
Macrophages
Macrophages are resident in almost all tissue and are the mature form of monocytes,
which circulate in the blood and continually migrate into tissues where they differenti-
ate. Macrophages are relatively long-lived cells and perform several different functions
8throughout the innate immune response and the subsequent adaptive immune response.
One is to engulf and kill invading microorganisms. In this phagocytic role they are
an important first defence in innate immunity and also dispose of pathogens and in-
fected cells targeted by an adaptive immune response. An additional and crucial role
of macrophages is to orchestrate the immune response: they help induce inflammation,
which is a prerequisite to a successful immune response, and they secrete signalling
proteins that activate other immune-system cells and recruit them into an immune re-
sponse (Murphy et al., 2008).
Lymphocytes
The common lymphoid progenitor in the bone marrow gives rise to the antigen-specific
lymphocytes of the adaptive immune system and also to a type of lymphocyte that
responds to the presence of infection but is not specific for a given antigen, and is thus
considered to be part of the innate immune system. This latter is a large cell with
a distinctive granular cytoplasm and is called a natural killer (NK) cell. There are
two types of lymphocytes: B-lymphocytes (B cells) and T-lymphocytes (T cells) each
with quite different roles in the immune system and distinct type of antigen receptors
(Murphy et al., 2008).
Natural Killer Cells
Natural killer cells are a part of the innate immune system, and are able to recognise
and kill some abnormal cells, for example some tumour cells and cells infected with
herpes viruses.
Natural killer cells are a class of lymphocytes that recognise infected and stressed cells
9and respond by killing these cells and by secreting the macrophage-activating cytokine
(Abbas and Lichtman, 2009). Natural Killer cells make up approximately 10% of the
lymphocytes in the blood and peripheral lymphoid organs. The cytotoxic mechanism
of NK cells is the same as the mechanism used by CTLs to kill infected cells.
T lymphocytes
T-cells are lymphocytes that originate from bone marrow stem cells but emigrate to
mature in the thymus, which they enter at the outer margin of the cortex, and are then
known as thymocytes. There are three main types of T-cells: killer T-cells (frequently
called cytotoxic lymphocytes or CTLs for short), helper T-cells, and regulatory T-cells.
The killer T-cells are a potent weapon that can destroy virus-infected cells. The sec-
ond type of T-cells is the helper T-cell, and this cell serves as the “quarterback” of
the immune system team. It directs the action by secreting protein molecules called
cytokines that have dramatic effects on other immune system cells. The third type of
T-cell, the regulatory T-cell, is still quite mysterious. Although it is believed that regu-
latory T-cells help keep other T-cells under control, it still isn’t clear exactly how they
do this or what ”under control” means in this context (Sompayrac, 2008).
2.3 Cancer Immune System Interactions
For over a century, cancer immunologists have sought to harness a patient’s immune
system to augment conventional therapies. Although ideas for boosting cancer immu-
nity have been regularly shown to work to some extent in animal models, the develop-
ment of useful routine immunotherapies for human cancer is still at an early stage. In
some cases, the immune response will be able to control or even eliminate the cancer,
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but in others the tumour load will be so great that the immune system will be over-
whelmed.
The result of interactions between immune system cells and tumour cells is equally de-
pendent on the functional state of the immune system cells, and on biological patterns
of tumour cells. The biological properties of tumour cells are reflected in: 1)recogni-
tion of tumour antigens; 2) the character of the immune response (growth inhibition or
stimulation, tolerance); 3) the expression of antitumour action of CTLs; 4) the forma-
tion of immunosuppression; 5) the influence of tumour cell patterns on the formation
of the microenvironment; 6) the development of resistance to CTLs action and drug
resistance; 7) the efficacy of immunotherapy etc. (Berezhnaya, 2010).
In mice which have been engineered so that one or more components of their im-
mune system is defective, an increased incidence of lymphoma, leukaemia, and virus-
associated cancer is well documented. However, the evidence that mice with compro-
mised immune systems experience an increase in solid tumours that do not involve a
virus infection is not compelling. Likewise, in humans there is strong evidence that a
weakened immune system can increase one’s chances of getting blood-cell and virus-
associated cancer.
2.3.1 Macrophages and NK Cells Against Cancer
Macrophage and natural killer cells may provide surveillance against some cancers.
Hyperactivated macrophages secrete tumour necrosis factor (TNF) and express it on
their surface. Either form of TNF can kill certain types of tumour cells in the best
tube. NK cells target cells that express low levels of class I Major histocompatibility
complex protein (MHC) molecules, and which display unusual surface molecules (e.g.
proteins which indicate that the target cells are “stressed”). There would be a number
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of advantage to having macrophages and NK cells provide surveillance against po-
tential cancer cells. First, unlike CTLs, which take a week or more to become fully
functional, macrophage and NK cells are fast-acting. This is an important considera-
tion, because the longer abnormal cells have to proliferate, the greater is the likelihood
they will mutate to take on the characteristic of metastatic cancer cells. Second, both
NK cells and macrophages recognise diverse target structures, so the chance of them
being fooled by a single mutation is small. In addition, macrophage are located out
in the tissue where most tumours arise, so they can intercept cancer cells at an early
stage. NK cells do not need to be activated to kill, since natural killer cells that are
circulating in the blood may be able to destroy either blood-cell cancers or cancer cells
that are metastasising through the blood from a primary tumour (Sompayrac, 2008).
2.3.2 CTLs Against Cancer
We describe the interactions between CTLs and some types of cancers: spontaneous
tumours, cancerous blood cells, and virus-associated tumours.
CTLs and spontaneous tumours
The majority of human cancers are spontaneous tumours that are not of blood-cell
origin, and it has been proposed that killer cells might provide surveillance against
these cancers. A CTL would have to perform an “unnatural act” to be activated by a
tumour out in the tissues i.e. it would have to break the “traffic laws”, and somehow
avoid being energised or killed. This could happen, but it would be very inefficient in
comparison to the activation of CTLs in response to viral infection. Another possible
scenario is that cancer cells from the primary tumour might metastasis to a lymph
node, where T-cells could be activated. However, by the time this happens, the original
12
tumour probably will have become quite large and this poses an additional problem.
A tumour cell’s high mutation rate is its greatest advantage over the immune system,
and usually keeps these cells one step ahead of surveillance by CTLs. So even when it
occurs, CTL surveillance is usually a case of “too little, too late” (Sompayrac, 2008).
CTLs and cancerous blood cells
One of the difficulties that CTLs have in providing surveillance against tumours that
arise in tissues is that these tumours simply are not on the normal traffic pattern of
the virgin T-cells, and it is hard to imagine how a CTL could be activated by a can-
cer it doesn’t see. In contrast, most blood cell cancers are found in the blood, lymph,
and secondary lymphoid organs, and this is ideal for viewing by CTLs, which pass
through these all the time. Thus, in the case of blood-cell cancers, the traffic pattern of
cancer cells and virgin T-cells actually intersect. Moreover, in contrast to tumours in
tissues, which usually are unable to supply the co-stimulation required for activation
of virgin T-cells, some cancerous blood cells actually express high levels of B7, and
therefore can provide the necessary co-stimulation. These properties of blood-cell can-
cers suggest that CTLs may provide surveillance against some of them. Unfortunately
this surveillance must be incomplete, because people with otherwise healthy immune
systems still get leukemias and lymphomas (Sompayrac, 2008).
CTLs and virus-associated tumours
Most viruses cause “acute” infections in which all the virus-infected cells are rather
quickly destroyed by the immune system. Since a dead cell is not going to make a
tumour, viruses which only cause acute infection do not play role in cancer. This
explains why most viral infections are not associated with human cancer.
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There are viruses, however, which can evade the immune system, and establish long-
term infections. Importantly, all viruses which have been shown to play a role in
causing cancer are able to establish long-term infections during which they “hide” from
the immune system. Because CTLs cannot destroy virus-infected cells while they are
hiding, and because these hidden cells are the very ones that eventually become cancer
cells, it can be argued that CTLs cannot provide significant surveillance against virus-
associated cancers. Also CTLs cannot provide significant surveillance against virus-
infected cells once they have become cancerous, because these cancers only result from
long-term viral infections i.e. infections which CTLs cannot detect or cannot deal with
(Sompayrac, 2008).
2.4 Tumour Immune Evasion
The immune response often fails to check tumour growth, because these responses are
ineffective or because tumours evolve to evade an immune attack. The immune system
faces a daunting challenge if it is to be effective against malignant tumours, because
any immune responses must kill all tumour cells and tumours grow rapidly. Often, the
growth of the tumour simply outstrips immune defences. The immune response against
tumours may be weak because many tumour antigens are weakly immunogenic, per-
haps because they differ only slightly from self-antigens. Growing tumours also de-
velop mechanisms for evading immune responses. Some tumours stop expressing the
antigens that are the targets of immune attack. These tumours are called “antigen loss
variants”. If the lost antigen is not involved in maintaining the malignant properties of
the tumour, the variant tumour cells continue to grow and spread (Abbas and Lichtman,
2009).
Cytotoxic CD8 T-cells are the best effector cells for killing tumour cells. One way in
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which tumour cells escape a cytotoxic T-cell is to stop expressing the autologous HLA
class I molecule that presents the tumour antigen to the T-cell. Between one-third and
one-half of all human tumours have a defective expression of one or more of their HLA
class I allotypes. That is, many patients have made a CD8 T-cells response against their
cancer but variant cells lacking particular HLA class I allotypes have escaped that im-
mune response and expanded to keep the cancer going (Parham, 2009). Loss of HLA
class I expression can in some circumstances make a tumour susceptible to attack by
NK cells. The killing of acute myelogenous leukaemia cells by alloreactive NK cells in
an HLA-haploidentical bone marrow transplant occurs because the recipient’s tumour
cells lack an HLA class I allotype that the donor-derived NK-cells see as “self”. This
is an example of NK-cells attacking a cell that is ‘missing self’.
As well as evading the immune response, tumours can also manipulate the immune
response in their favour. In the absence of inflammation, tumour-cell antigens can be
processed and presented to cells by dendritic cells that lack B7 co-stimulators. As a
result, the tumour secretes cytokines such as TGF-β that create an immunosuppressive
environment in the tumour, which can be reinforced by the recruitment of regulatory
cells (Parham, 2009).
Chapter 3
Mathematical Background
A mathematical model is an abstract, simplified mathematical construction to part of
the “real world” and is created for a specific purpose, i.e., it is designed to mimic
reality by using the language of mathematics. Mathematical models contribute to an
understanding of the real system which is being modelled. Such simulation helps us to
look at reality more deeply and with a heightened understanding. A good mathematical
model can be used to: (1) help confirm or reject hypotheses about complex systems; (2)
reveal contradictions or incompleteness of data and/or hypotheses; (3) predict system
performance under untested or presently untestable conditions; (4) predict and supply
information on the value of experimentally inaccessible variables; and finally, (5) a
good mathematical model may suggest the existence of new unobserved phenomena.
Modelling can help us avoid, or reduce the need for costly, undesirable or impossible
experiments in the real world. In this chapter, we present some technical background
we will use to analyse our mathematical models, especially reaction-diffusion models
and we will explain travelling wave solutions of these models. Also we will describe
the phenomenon of diffusion-driven instability and then limit cycle behaviour through
Andronov-Hopf bifurcations.
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3.1 Reaction Diffusion Equations
The dynamics of reactive mixtures results from local transformation process, chemical
reactions, and transport in space, diffusion. These process are typically modelled by a
standard reaction-diffusion equation
∂ρ
∂ t
= D
∂ 2ρ
∂x2
+F(ρ), (3.1)
where ρ is a vector of concentration of the diffusing species, D is the diffusion ma-
trix, and F is a kinetic term describing reactions or interactions between the species.
Reaction-diffusion models are not limited to the field of chemistry and chemical en-
gineering. They can describe the dynamics of nonchemical systems, and reaction-
diffusion equations provide a general theoretical framework for the study of phenom-
ena in areas such as biology, ecology, physics, and materials science (Mendez et al.,
2010).
3.1.1 Rate Equations
If spatial effects can be neglected, many systems in chemistry, biology, ecology, physics,
and other areas can be described by rate equations, i.e. a set of ordinary differential
equations. Systems may be homogeneous because the system is small enough and
transport is efficient enough to eliminate spatial gradients, or the spatial homogeneity
may be imposed from the outside. We consider systems consisting of individuals, e.g.,
microorganism or animals, or particles, e.g., molecules of n different species. We as-
sume that the system is large enough that a continuum, mean-field description is valid,
i.e., the internal fluctuations due to the discrete nature of the constituents can be ne-
glected. The evolution of the densities or concentrations is governed by the kinetic
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equations:
∂ρ
∂ t
= F(ρ,µ), (3.2)
where ρ ∈ Rn and F : Rn → Rn. For systems of particles, the coefficients or pa-
rameters of the rate terms, µ , are real numbers. Evolution equations for systems of
particles must posses certain properties to be acceptable descriptions. The densities ρi,
i=1,...,n, cannot be negative. Therefore the kinetic Equations must preserve positivity,
i.e., ρi(0)≥ 0 at time t = 0 implies ρi(t)≥ 0 for all times t > 0.
Equations (3.2) have this property if
Fi(ρ1, ...,ρi−1,0,ρi+1, ...,ρn)≥ 0.
It is sometimes convenient to split the rate function Fi into its positive and negative
parts, i.e., write it in production-loss form:
Fi(ρ) = F+i (ρ)−F−i (ρ),
where F+i (ρ) ≥ 0 and F−i (ρ) ≥ 0. The first term, F+i , is the production or birth term
and captures the processes that increase the chemical concentration or population den-
sity. The second term, F−i , is the loss or death term and captures the processes that
decrease the concentration or density.
3.1.2 Linear Stability Analysis
Studies of the dynamics of a system generally pay little attention to transient behaviour
and focus instead on the ultimate fate of the system, the asymptotic state it attains as
time goes to infinity. These can be stationary state, time-dependent periodic states, or
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time-dependent aperiodic or chaotic states. Our interest here is the former, the station-
ary or steady states and their properties.
Let ρ¯ be a stationary state of (3.2):
F(ρ¯) = 0.
The stationary state ρ¯ is stable if trajectories that start sufficiently close to it stay close
to the steady state. This is more formally stated in the following definition:
Definition 3.1.1 The Stationary state ρ¯ is Lyapunov stable if for any ε > 0, there exists
a δ > 0 (depending on ε) such that for all initial condition ρ(0) = ρ0 with |ρ0− ρ¯|< δ
we have |ρ(t)− ρ¯|< ε for all t > 0.
This definition states only that a stationary state is stable if the system does not wander
too far away when starting close enough to the steady state. The next definition is a
stronger notion of stability, namely that the system actually returns to the steady state
after a sufficiently small perturbation (Mendez et al., 2010).
Definition 3.1.2 The Stationary state ρ¯ is asymptotically stable in the sense of Lya-
punov, if there exists an η such that if |ρ0− ρ¯|< η then
lim
t→∞ |ρ(t)− ρ¯|= 0.
The stationary state ρ¯ is globally asymptotically stable if η can be arbitrarily large
(Mendez et al., 2010). Let δ (t) = ρ(t)− ρ¯ . The evolution of the perturbation δ (t) is
given by
dδ
dt
= Jδ +N(δ ),
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where N(δ ) = o(δ ) as δ → 0, i.e., |N(δ )/δ | → 0 as |δ | → 0. The n×n matrix J is the
Jacobian matrix of the system evaluated at the steady state ρ¯ and is given by
∂Fi
∂ρ j
∣∣∣∣∣
ρ¯
.
Neglecting the small nonlinear terms N(δ ), we obtain the linearised system, with re-
spect to the steady state ρ¯ , for (3.2):
dδ
dt
= Jδ . (3.3)
Let λi, i=1,...,n, be the eigenvalues of the Jacobian J and Φi, i=1,...,n, the associated
eigenvectors. For the generic case that all eigenvalues are distinct, the solution of (3.3)
is given by
δ (t) =
n
∑
i=0
aiΦiexp(λit),
where ai are constants determined by the initial condition δ (0). If all eigenvalues of
the Jacobian have a negative real part, Reλi < 0 for i=1,...,n, then the perturbations
decay, i.e., the solution of the linearised equation (3.3) approaches 0. If there exists at
least one λi′ with a positive real part, Reλi′ > 0 then the system moves away from the
steady state. The stability of the steady state ρ¯ is determined by the eigenvalues of the
Jacobian. That is the content of the following theorem.
Theorem 3.1.1 (a) if all the eigenvalues λi, i=1,...,n, of the Jacobian matrix J have a
negative real part, then the steady state ρ¯ of the nonlinear evolution (3.2) is asymp-
totically stable. (b) if at least one eigenvalue of J has a positive real part, then the
steady state ρ¯ is unstable. (c) If the Jacobian has one or more eigenvalues with zero
real part and no eigenvalues with positive real part, then the steady state ρ¯ may be
stable, unstable, or asymptotically stable depending on the nonlinear terms.
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The eigenvalues λi of J are the roots of the nth order characteristic polynomial,
(−1)ndet(J−λ In) = 0, where In is the n×n identity matrix,
λ n+ c1λ n−1+ c2λ n−2+ ...+ cn−1λ + cn = 0.
3.1.3 Diffusion
In an assemblage of particles, for example, cells, bacteria, chemicals, animals and so
on, each particle usually moves around in a random way. The particles spread out as
a result of this irregular individual particles motion. When this microscopic irregular
movement results in some macroscopic or gross regular motion of the group we can
think of it as a diffusion process (Murray, 2002). The classical approach to diffusion
considers Fickian diffusion which states that the flux, J, of material, which can be
cells, concentration of chemical, number of animals and so on, is proportional to the
gradient of the concentration of the material. That is, in one-space dimension:
J ∝−∂ρ
∂x
⇒ J =−D∂ρ
∂x
, (3.4)
where ρ(x, t) is the concentration of the species and D is its diffusivity. The minus sign
simply indicates that diffusion transports matter from a high to a low concentration.
We now write a general conservation equation which says that the rate of change of
the amount of material in a region is equal to the rate of flow across the boundary plus
any that is created within the boundary. If the region is x0 < x< x1 and no material is
created,
∂
∂ t
∫ x1
x0
ρ(x, t)dx= J(x0, t)− J(x1, t).
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If we take x1 = x0 +∆x, take the limit as ∆x→ 0 and use (3.4) we get the classical
diffusion equation in one dimensional, namely,
∂ρ
∂ t
=−∂J
∂x
=
∂ (D∂ρ∂x )
∂x
,
which, if D is constant, becomes
∂ρ
∂ t
= D
∂ 2ρ
∂x2
. (3.5)
If we release an amount Q of particles per unit area at x = 0 at t = 0, that is,
ρ(x,0) = Qδ (x).
where δ (x) is the Dirac delta function, then the solution of (3.5) is
ρ(x, t) =
Q
2(piDT )1/2
e−x
2/(4Dt), t > 0.
3.1.4 Chemotaxis
A large number of insects and animals (including humans) rely on an acute sense of
smell for conveying information between members of the species. Chemicals which
are involved in this process are called pheromones. For example, the female silk moth
Bombyx mori exudes a pheromone, called bombykol, as a sex attractant for the male,
which has a remarkably efficient antenna filter to measure the bombykol concentration,
and it moves in the direction of increasing concentration. In this thesis we model
chemically directed movement, which is called chemotaxis, which, unlike diffusion,
directs the motion up a concentration gradient. It is not only in animal and insect
ecology that chemotaxis is important. It can be equally crucial in biological processes
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where there are numerous examples. For example, when a bacterial infection invades
the body it may be attacked by movement of cells towards the source as a result of
chemotaxis. Convincing evidence suggests that leukocyte cells in the blood move
towards a region of bacterial inflammation, to counter it, by moving up a chemical
gradient caused by the infection.
Let us suppose that the presence of a gradient in an attractant, a(x,t), gives rise to a
movement, of the cells say, up the gradient. The flux of cells will increase with the
number of cells, ρ(x, t), present. Thus we may reasonably take as the chemotactic flux
J = ρχ(a)∇a, (3.6)
where χ(a) is a function of the attractant concentration. In the general conservation
equation for ρ(x, t), namely
∂ρ
∂ t
+∇ · J = f (ρ),
where f (ρ) represents the growth term for the cells, the flux
J = Jdi f f usion+ Jchemotaxis
where the diffusion contribution is from J = −D∇ρ , with the chemotaxis flux from
(3.6). Thus a basic reaction-diffusion-chemotaxis equation is
∂ρ
∂ t
= f (ρ)−∇ ·ρχ(a)∇a+∇ ·D∇ρ,
where D is the diffusion coefficient of the cells.
Since the attractant a(x,t) is a chemical it also diffuses and is produced, by the amoebae,
for example, so we need a further equation for a(x, t). Typically
∂a
∂ t
= g(a,ρ)+∇ ·Da∇a,
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where Da is the diffusion coefficient of a and g(a,ρ) is the kinetics/source term, which
may depend on ρ and a. Normally we would expect Da > D (Murray, 2002).
3.1.5 Non-Dimensionalisation
Non-dimensionalisation is the partial or full removal of units from an equation involv-
ing physical quantities by a suitable substitution of variables. It is the first and arguably
the most important step in the analysis of a system of differential equations. It involves
scaling each variable (dependent and independent) by a typical or reference value, leav-
ing a non-dimensional variable whose typical scale is O(1). Non-dimensionalisation
or problem normalisation has several important uses:
1. It identifies the dimensionless groups (ratios of dimensional parameters) which
control the solution behaviour.
2. Terms in the equations are now dimensionless and so allows comparison of their
sizes.
This allows the identification of the important (i.e. dominant) terms in the equa-
tions and their interactions in different regimes, giving insight into the structure
of solutions and the dominant physical mechanisms at work.
In particular, negligible terms can be identified leading to simplification in many
circumstances.
3. It allows estimates of the effects of a additional features to the original model
through the new dimensional group(s) associated with the additional term(s).
This allows measuerment of the effect of the physical feature(s) in the model.
4. Finally, it can reduce the number of parameters occurring in the problem by
formation the nondimensional parameters or dimensionless groups.
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Non-dimensionalisation steps
To non-dimensionalise a system of equations, one must do the following:
1. Identify all the independent and dependent variables;
2. Replace each of them with a quantity scaled relative to a characteristic unit of
measure to be determined;
3. Divide through by the coefficient of the highest order polynomial or derivative
term;
4. Choose judiciously the definition of the characteristic unit for each variable so
that the coefficients of as many terms as possible become 1;
5. Rewrite the system of equations in terms of their new dimensionless quantities.
3.2 Travelling Wave Solutions
Travelling wave solutions are solutions of special type. They can be usually charac-
teristic as solution invariant with respect to translation in space. A travelling wave is
taken to be a wave which travels without change of shape, and If a solution ρ(x, t)
represents a travelling wave, the shape of the solution will be the same for all time and
the speed of propagation of this shape is a constant, which we denote by c (Adam and
Bellomo, 1997). A mathematical way of saying this is that if the solution
ρ(x, t) = ρ(x− ct) = ρ(z), z= x− ct, (3.7)
then ρ(x, t) is a travelling wave, and it modes at constant speed c in the positive x-
direction. A wave which moves in the negative x-direction is of the form ρ(x+ ct).
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When we look for travelling wave solutions of an equation or system of equations in x
and t in the form (3.7), we have ∂ρ/∂ t =−c dρ/dz, and ∂ρ/∂x= dρ/dz. So partial
differential equations in x and t become ordinary differential equations in z.
It is part of the classical theory of linear parabolic equations, such as (3.5), that there
are no physically realistic travelling wave solutions. Suppose we look for solutions in
the form (3.7); then (3.5) becomes
D
∂ 2ρ
∂ z2
+ c
∂ρ
∂ z
= 0 ⇒ ρ(z) = A+Be−cz/D,
where A and B are integration constants. Since ρ has to be bounded for all z, B must
be zero since the exponential becomes unbounded as z→ ∞. ρ(z) = A, a constant, is
not a wave solution. In marked contrast the parabolic reaction diffusion equation (3.1)
can exhibit travelling wave solutions, depending on the form of the reaction/interaction
term f (ρ). This solution behaviour was a major factor in starting the whole mathemat-
ical field of reaction diffusion theory. Although most realistic models of biological in-
terest involve more than one dimension and more than one dependent variable, whether
concentration or population, there are several multi-species systems which reasonably
reduce to a one-dimensional single- species mechanism which captures key features.
3.3 Diffusion-Driven Instability
A reaction diffusion system exhibits diffusion-driven instability, sometimes called Tur-
ing instability, if the homogeneous steady state is stable to small perturbations in
the absence of diffusion but unstable to small spatial perturbations when diffusion
is present. The concept of instability in biology is often in the context of ecology,
where a uniform steady state becomes unstable to small perturbations and the popu-
lations typically exhibit some temporal oscillatory behaviour. The instability we are
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concerned with here is of a quite different kind. The main process driving the spatially
inhomogeneous instability is diffusion: the mechanism determines the spatial pattern
that evolves. How the pattern or mode is selected is an important aspect of the analysis,
a topic we discuss in this (and later) chapters. We derive here the necessary and suffi-
cient conditions for diffusion-driven instability of the steady state and the initiation of
spatial pattern for the general system
∂u
∂ t
= ∇2u+ γ f (u,v),
∂v
∂ t
= d∇2v+ γg(u,v), (3.8)
(n.∇)
 u
v
 = 0, r on ∂B; u(r,0),v(r,0) given
where ∂B is the closed boundary of the reaction diffusion domain B and n is the unit
outward normal to ∂B. The relevant homogeneous steady state (u0,v0) of (3.8) is the
positive solution of
f (u,v) = 0, g(u,v) = 0.
With no spatial variation u and v satisfy
ut = γ f (u,v), vt = γg(u,v) = 0. (3.9)
Linearising about the steady state (u0,v0), we set u−u0
v− v0
 (3.10)
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and (3.9) becomes, for | w | small,
wt = γ Aw, A=
 fu fv
gu gv

u0,v0
(3.11)
where A is the stability matrix. We now look for solutions in the form
w ∝ eλ t , (3.12)
where λ is the eigenvalue. The steady state w = 0 is linearly stable if Re λ < 0 since in
this case the perturbation w→0 as t→∞. Substituation of (3.12) into (3.11) determines
the eigenvalues λ as the splutions of
| γA−λ I |=
∣∣∣∣∣∣∣
γ fu−λ γ fv
γgu γgv−λ
∣∣∣∣∣∣∣= 0 (3.13)
⇒ λ 2− γ( fu+gv)λ + γ2( fugv− fvgu) = 0,
so
λ1,λ2 =
1
2
γ
[
( fu+gv)±{( fu+gv)2−4( fugv− fvgu)}1/2
]
.
Linear stability, that is , Re λ < 0, is guaranteed if
trA= fu+gv < 0, | A |= fugv− fvgu > 0. (3.14)
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Now consider the full reaction diffusion system (3.8) and again linearise about the
steady state, which with (3.10) is w = 0, to get
wt = γ Aw+D∇2w, D=
 1 0
0 d
 . (3.15)
To solve this system of equations subject to the boundary conditions (3.8) we first de-
fine W(r) to be the time-independent solution of the spatial eigenvalue problem defined
by
∇2W + k2W = 0, (n.∇)W = 0 f or r on ∂B (3.16)
where k is the eigenvalue. For example, if the domain is one-dimensional, say, 0≤ x≤
a, W ∝ cos(npix/a) where n is an integer; this satisfies zero flux conditions at x = 0
and x = a. The eigenvalue in this case is k = npi/a. So 1/k = a/npi is measure of the
wavelike pattern: the eigenvalue k is called the wavenumber and 1/k is proportional to
the wavelength ω;ω = 2pi/k = 2a/n in this example.
Let Wk(r) be the eigenfunction corresponding to the wavenumber k. Each eigenfunc-
tion Wk satisfies zero flux boundary conditions. Because the problem is linear we now
look for solutions w(r, t ) of (3.15) in the form
w(r, t) = ∑
k
ckeλ tWk(r), (3.17)
where the constants ck are determined by a Fourier expansion of the initial conditions
in terms ofWk(r). λ is the eigenvalue which determines temporal growth. Substituting
this form into (3.15) with (3.16) and cancelling eλ t , we get, for each k,
λWk = γAWk+D∇2Wk
= γAWk−Dk2Wk. (3.18)
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We require nontrivial solution for Wk so the λ are determined by the roots of the char-
acteristic polynomial
| λ I− γA+Dk2 |= 0.
Evaluating the determinant with A and D from (3.11) and (3.15) we get the eigenvalues
λ (k) as functions of the wavenumber k as the roots of
λ 2+λ [k2(1+d)− γ( fu+gv)]+h(k2) = 0,
h(k2) = dk4− γ(d fu+gv)k2+ γ2 | A | . (3.19)
The steady state (u0,v0) is linearly stable if both solutions of (3.19) have Re λ < 0.
We have already imposed the constraints that the steady state is stable in the absence
of any spatial effects; that is, Re λ (k2 = 0) < 0. The quadratic (3.19) in this case is
(3.12) and the requirement that Re λ < 0 gave conditions (3.14). For the steady state
to be unstable to spatial disturbances we require Re λ (k) > 0 for some k 6= 0. This
can happen if either the coefficient of λ in (3.19) is negative, or if h(k2)< 0 for some
k 6= 0. Since ( fu+gv) < 0 from conditions (3.14) and k2(1+d) > 0 for all k 6= 0 the
coefficient of λ , namely,
[k2(1+d)− γ( fu+gv)]> 0,
so the only way Re λ (k2) can be positive is if h(k2)< 0 for some k.
3.4 Limit Cycles and Andronov-Hopf bifurcations
Most dynamical systems contain parameters in addition to the dependent and inde-
pendent variables. A general system of ordinary differential equations (ODEs) could
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therefore be written
x˙= f (x,k),
where k is a set of parameters on which the equations, and thus their solutions, depend.
If we solve a set of differential equations at different parameter values, we often find
that, qualitatively, not much changes. However, in some models, we can find sets of
parameter values which are close to each other but where the behaviour of the model
is in some way qualitatively different for one set or the other. For instance, a sta-
ble equilibrium point might have become unstable. We then say that the system has
undergone a bifurcation. Bifurcations often change the attractors of a dynamical sys-
tem. Informally, an attractor is a solution which is approached at long times. Stable
equilibrium points are attractors, but they are not the only possibility. We will engage
in some simple numerical discovery exercises in which we will see a few important
bifurcations and their consequences. We will use the dynamical systems software xp-
paut (xpp for short). One very important kind of bifurcation is the Andronov-Hopf
bifurcation (formerly known in the West as a Hopf bifurcation). In an Andronov-Hopf
bifurcation, a stable focus becomes an unstable focus as a parameter is varied, and
the attractor becomes a limit cycle. A limit cycle is an asymptotically stable, peri-
odic solution which can be pictured as a closed curve in phase space. Limit cycles
differ from conservative oscillations in mechanical systems in that the former have
fixed shapes and sizes at given parameter values, while the corresponding quantities
in a conservative mechanical oscillator depend on the total energy, i.e. on the initial
conditions. There are two qualitatively different kinds of Andronov-Hopf bifurcations,
supercritical Andronov-Hopf bifurcation and subcritical Andronov-Hopf bifurcation.
In a supercritical Andronov-Hopf bifurcation, the limit cycle grows out of the equilib-
rium point. In other words, right at the parameters of the Andronov-Hopf bifurcation,
the limit cycle has zero amplitude, and this amplitude grows as the parameters move
further into the limit-cycle regime. Pictorially, think of it this way:
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In a subcritical Andronov-Hopf bifurcation, there is an unstable limit cycle surround-
ing the equilibrium point, and a stable limit cycle surrounding that. The unstable limit
cycle shrinks down to the equilibrium point, which becomes unstable in the process.
For systems started near the equilibrium point, the result is a sudden change in be-
haviour from approach to a stable focus, to large-amplitude oscillations. Here is the
corresponding picture: Because the stable limit cycle exists even when the equilibrium
point is stable, if we imagine slowly varying a system parameter back-and-forth across
the Andronov-Hopf bifurcation, we wouldnt expect to jump back to the equilibrium
point at the same parameter value of the parameter from which this point lost stabil-
ity. This is called hysteresis, and is associated with bistability, the fact that the system
actually has two attractors over a range of parameters. In both cases, Andronov-Hopf
bifurcations occur when an equilibrium point changes from being a stable to an un-
stable focus. We therefore detect Andronov-Hopf bifurcations through linear stability
analysis.
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3.5 Numerical Methods
In this thesis, we are normally going to simulate the models we have developed by
using four different software packages, i.e., MATLAB, MAPLE, COMSOL and XP-
PAUT. In MATLAB we will use the ODE solver ode45 to find the numerical solutions
to ordinary differential equations, and the PDE solver pdepe to find the numerical so-
lutions of partial differential equations. ode45 is a standard solver for ordinary differ-
ential equations. This function implements a Runge-Kutta method with a variable time
step for efficient computation. It is design to handle the following general problem:
∂x
∂ t
= f (t,x), x(t0) = x0,
where t is the independent variable, x is a vector of dependent variables to be found and
f(t,x) is a function of t and x. pdepe solves a class of parabolic/elliptic PDE systems
by converting the PDEs to ODEs using a second-order accurate spatial discretisation
based on a set of nodes specified by the user. The time integration is done with the rou-
tine ode15s. These systems involve a vector-valued unknown function u that depends
on a scalar space variable, x, and a scalar time variable, t. The general class to which
pdepe applies has the form:
c(x, t,u,
∂u
∂x
)
∂u
∂ t
= x−m
∂
∂x
(xm f (x, t,u,
∂u
∂x
))+ s(x, t,u,
∂u
∂x
),
where a≤ x≤ b and t0 ≤ t ≤ t f . The integer m can be 0, 1, or 2, corresponding to slab,
cylindrical, and spherical symmetry, respectively. The function c is a diagonal matrix
and the flux and source functions f and s are vector valued. We using MAPLE to
solve algebraic equations which are obtained by removing all the temporal and spatial
derivative terms of the mathematical models. These solutions give us the steady states
of the models. Also we use MAPLE to make a linearisation of the model by calculating
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the Jacobian matrix at the steady state, which determine the stability of the steady
states. We use COMSOL to calculate the numerical simulation of partial differential
equations in 2D, by using the Finite Element Method. XPPAUT is used to find any
Hopf-bifurcations.
Chapter 4
Literature Review
In this chapter we review some of the key papers in the mathematical modelling of
cancer, and we focus specifically on the mathematical modelling of tumour-immune
interactions. Also we give a brief review of mathematical models of invasion and an-
giogenesis.
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Figure 4.1: Schematic diagram of the basic local lymphocyte-cancer cell interactions
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4.1 Immune Response-Cancer Interaction Models
The Model of Matzavinos et al.
In the work of Matzavinos et al., the authors proposed a spatiotemporal model of the
interactions between tumour cells and cytotoxic T-lymphocytes (CTLs) (Matzavinos
et al., 2004; Chaplain and Matzavinos, 2006) by including the spatial motility of both
tumour cells and CTLs, as well as chemotactic motion of the CTLs. They focused
mainly on the role of the immune system in determining dormant states of the tumour,
by showing, through a series of simulations, that a dormant state is reached, but the
tumour cells are spatially distributed in an irregular pattern, which also temporally os-
cillates in a non-periodic fashion.
The interplay between tumour cells and tumour-infiltrating cytotoxic-T-lymphocytes
can be modelled as shown in figure 4.1 (see: Matzavinos et al. (2004)), where T de-
notes a tumour cell, E denotes an effector cell (CTL), C denotes the complex formed,
T ∗ denotes a dead tumour cell and E∗ denotes a dead effector cell. The following
assumptions are made:
• the complexes C consist of a tumour cell and a CTL forming at a rate k+. The
parameter k+ consists of the encounter rate between a tumour cell and a CTL,
the probability that the CTL recognizes the tumour cell as a “non-self” entity,
and also the probability that the tumour cell forms a complex with the CTLs
• the break-up of complexes can lead to a situation where both the tumour cell and
the CTLs are alive with a rate k−
• the break-up of complexes can lead to a situation where either the immune cell
or the tumour cell survives the encounter with a rate k
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• the probability that a tumour cell is killed is p, and correspondingly the proba-
bility that a CTL is killed (i.e. the tumour cells survives) is (1− p)
Using the Law of Mass Action, this leads to the following system of differential equa-
tions describing these specific kinetic interactions (figure 4.1):
∂tC = k+ET − (k−+ k)C
∂tT =−k+ET + k−C+ k(1− p)C (4.1)
∂tE =−k+ET + k−C+ kpC
The authors added the diffusion terms to the system (4.1) and considered diffusion of
the chemokine. They assumed all random motility, chemotaxis and diffusion coeffi-
cients are constant. The numerical simulation of this model demonstrated the existence
of dynamics that are quasi-stationary in time but heterogeneous in space. A subsequent
linear stability analysis of the underlying (spatially homogeneous) ODE kinetics cou-
pled with the numerical investigation of the ODE system revealed the existence of a
stable limit cycle in the corresponding phase space. This was verified by the bifurca-
tion analysis.
The Model of Owen and Sherratt
As far as spatial aspects are concerned, Owen and Sherrat (Owen and Sherratt, 1997,
1999) developed a detailed spatiotemporal model focused on the role of macrophages.
They showed that the presence of chemo-attraction of macrophages towards the tumour
cells implies both the onset of traveling waves and a heterogeneous spatial distribution
of the tumour cells. In Owen and Sherratt (1997), the authors presented the main prop-
erties and interactions of such tumour-associated macrophages, leading to a description
of a mathematical model for the spatial interactions of macrophages, tumour cells and
37
f + l+m
k1- c+ f -c l+debris
k2
Figure 4.2: Schematic diagram of the macrophage-cancer cell interactions
normal tissue cells, and they focused on the ability of macrophages to kill mutant cells
(figure. 4.2).
The authors showed that the rapid diffusion of chemical regulators in comparison to
cell movement, combined with the anti-tumour effects of macrophages, can lead to the
onset of instability and the appearance of hot-spots of tumour cell density. Also they
showed that while the tumouricidal activity of macrophages is insufficient to eliminate
tumours, it can have important implications for their structure. They demonstrated that
chemotaxis can stabilise the homogeneous tumour steady state behind the wave, but
can also initiate spatiotemporally irregular solutions. These results raise a key ques-
tion about the effect of chemotaxis in the more realistic two and three dimensional
setting. In Owen and Sherratt (1999), the authors presented a mathematical model of
reaction-diffusion form, which represents the influx of macrophage into a small avas-
cular tumour, and their dynamics within the tumour as it grows. This model predicts
that macrophages are unable to spontaneously eliminate whole tumours, in keeping
with the conventional view that without intervention, the immune system is an ineffec-
tive weapon against the majority of cancers. Nevertheless, this model predicts that the
ability of macrophages to selectively kill tumour cells has a extremely significant effect
on tumour development, since it is able to induce spatial inhomogeneities. This work
suggested that the anti-tumour activity may nevertheless be crucial in establishing the
spatial structure that is able later, to induce angiogenesis. From the numerical bifur-
cation study, the authors suggested that the mechanism by which these occur is that a
stationary spatial (Turing) pattern becomes unstable via a Hopf bifurcation, while the
homogeneous equilibrium from which the turing pattern bifurcated remains kinetically
stable.
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The Model of dePillis et al.
de Pillis et al. (2005) described tumour-immune interactions and focussed on the role
of natural killer (NK) and CD8+T cells in tumour surveillance, with the goal of un-
derstanding the dynamics of immune-mediated tumour rejection. The functions of the
model describing tumour-immune growth, response, and interactions rates, as well as
associated variables, are developed using a least-squares method combined with a nu-
merical differential equations solver. Also the authors discussed the variable sensitivity
analysis. The model assumptions are as follows:
1. The tumour cells grow logistically in the absence of an immune response.
2. Both NK and CD8+T cells can kill tumour cells.
3. Tumour cells have the potential to engender cytocidal activity in previous naive
and noncytotoxic cells.
4. As a part of the innate immunity, NK cells are always present and active in the
system, even in the absence of tumour cells.
5. As a part of the specific immunity, tumour specific CD8+T cells are recruited
once tumour cells are present.
The mathematical model suggests the value in continuing to research the mechanisms
by which NK cells and CD8+T cells induce tumour cells lysis. The authors hypothesise
that the more effective the immune cell kill is, the more closely it follows a rational
law dynamics. Model results seem to indicate that to promote tumour regression, it
may be necessary to focus on increasing CD8+T cell activity. The authors propose
that the there may be a direct positive correlation between the patient-specific efficacy
of the CD8+T cell response, as measured by cytotoxicity assays, and the likelihood of
a patient favourably responding to immunotherapy treatments.
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Figure 4.3: Schematic diagram of the basic local lymphocyte-cancer cell interactions
from the paper of Kuznetsov et al.
The Model of Kuznetsov et al.
Kuznetsov et al. (1994) presented a mathematical model of cytotoxic T-lymphocyte
(CTL) response to an immunogenic tumour. They described the kinetics of growth
and regression of the B-lymphoma BCL1 in the spleen of mice. Figure 4.3 shows the
interactions between effector cells (E) and tumour cells (T) in vitro, where C is the
effector cell-tumour cell conjugate, E∗ is inactivated effector cells, and T ∗ is “lethally
hit” tumour cells.
This model has four steady states, the low tumour steady state is stable, and it refers
to the ”dormant tumour” steady state. The high tumour and low effector level steady
state is also stable, and it corresponds to relatively “uncontrolled” tumour growth or
“tumour escape”.
Also the authors used bifurcation analysis to explore the critical parameter values
where the qualitative behaviour predicted. µ = k3/k2 is a critical parameter in the
model. With small µ the model predicts that BCL1 tumours do not efficiently inacti-
vate effector cells. They also show the model does have stable spirals, but the Dulac-
Bendixson criterion demonstrates there are no stable closed orbits.
This model show that there may be a connection between the phenomenon of im-
munostimulation of tumour growth, the “sneaking through” of a tumour, and the for-
mation of the tumour “dormant state”.
40
From this model one can speculate that even in the presence of a cell-mediated im-
mune response, which in this model does not totally eliminate even highly immuno-
genic tumours, a multitude of dormant tumours could accumulate in body tissue with
increasing age. This model can be applicable to other processes in biology such as the
infection of T-cells by HIV.
The Model of Webb et al.
Webb et al. (2002) developed a mathematical model based on tumour cell-lymphocyte
interactions and the cell surface expression of Fas and FasL, and also extended the
model to include the involvement of Matrix Metalloproteinases (MMP) and the catal-
ysed soluble degradation product of the ligand (sFasL). This model consisted of ordi-
nary differential equations which represent the interactions of two cell types: armed ef-
fector T-cells, and FasL positive tumour cells. They based the model upon the demon-
stration that the certain type of human tumours can produce functional FasL and can
induce the apoptotic killing of activated lymphocytes in vitro. The key features in the
model are the constitutive expression and engagement of membrane bound FasL on
tumours with Fas expressed on the surface of activated lymphocytes, and the down-
regulation of the cell surface Fas in tumours.
The authors predict that the production of soluble forms of Fas and FasL will lead to
down-regulation of the immune response by neutralising the Fas ligand or receptor.
Moreover, the inclusion of MMP inactivation in the model results in increased trans-
membrane FasL and leads to a higher rate of Fas-mediated apoptosis for lymphocytes
that for tumour cells. The clinical implications of this model are two-fold. Firstly, ele-
vated levels of MMPs in tumours and their association with invasion and angiogenesis
have led to the development of board spectrum MMP inhibitors as potential therapeutic
agents, and several compounds are undergoing clinical trails in cancer patients. Such
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therapies could be compromised by the predicted adverse effect of MMP inactivation
on FasL and lymphocyte apoptosis. On the other hand, MMP-7 inactivation would ef-
fectively lead to decreased levels of sFasL and this down-regulation may abrogate the
suppressive effect of the soluble ligand on neutrophilic inflammation and could result
in tumour regression. Secondly, many tumours cell types are resistant to Fas-mediated
apoptosis and these cells often have the capability of killing activated lymphocytes
via expression of FasL. They suggest, therefore, that the Fas/FasL system may have
an important impact on the outcome of numerous ongoing immunotherapeutic trials
based upon, for example, antigenic peptide presentation, costimulation and activation
of lymphocytes/dendritic cells.
The Model of Kirschner et al.
Immunotherapy with the cytokine interleukin-2 (IL-2) may boost the immune system
to fight tumours. Kirschner and Panetta (1998) showed by the mathematical model the
dynamics between the tumour cells, immune-effector cells, and IL-2. These efforts
are able to explain both short tumour oscillations in tumour size as well as long-term
tumour relapse. Also they explored the effect of adoptive cellular immunotherapy on
the model and described under what circumstances the tumour can be eliminated. The
model consist of three populations, E(t) the activated immune-system cells; T(t) tu-
mour cells; and IL(t), the concentration of IL-2. This model have four steady state, the
trivial steady state is saddle, from the bifurcation diagram, they found the parameter
c, the tumour antigenicity is the bifurcation parameter. The antigenicity of the tumour
play the key role of the dynamics. For low antigenic tumours immune system is not
able to clear the tumour, while, for highly antigenic tumours, reduction to a small dor-
mant tumour is the best case scenario. This model has a stable limit cycles which
imply that the tumour and the immune system undergo oscillations. If the tumour has
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a low to medium antigenicity these cycles are relatively long with large amplitudes
and the tumour is in a dormant state during most of the period. This may explain long
term recurrence of tumour. If the tumour has medium to high antigenicity the period
of cycles are short with small amplitudes.
Also the authors studied the treatment of the tumour-immune system with immunother-
apy. Two type of treatment are explored individually and together, Adoptive cellular
immunotherapy (ACI) and administration of the cytokine IL-2. Treatment with IL-
2 alone does not offer a satisfactory outcome; if IL-2 administration is low there is
no tumour-free state. However, if IL-2 input is high the tumour can be clear but the
immune system grow without bounds causing problems such as capillary leak syn-
drome. Treatment with ACI and IL-2 that gives the combined effects obtained from
the monotherapy regimes. Cytokine-enhanced immune function can play a significant
role in treatment of cancer.
The Model of Eftimie et al.
Eftimie and Bramson (2011) reviewed spatially homogeneous mechanistic mathemat-
ical models describing the interactions between a malignant tumour and the immune
system. They showed some models with, one, two , three, and four equations. In the
one equation model they take simple model to described the tumour growth patterns,
involving a single ordinary differential equation (ODE). These model describe only one
cell population (cancer cell), which are subject to self-regulation by density dependent
processes. In the two equation model, the authors added the effector equation to the
model of first equation. they consider a generic effector cell population interacting with
tumour cells. These interactions are described by two equations, which are of predator
pray type. The immune cells play the role of the predator, while the tumour cells are
the prey. This model is very helpful for elucidating basic (generic) mechanisms that
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can induce observed behaviour, such as tumour regression and tumour dormancy. In
the three equations model, the authors consider how the three-equation models help to
uncover the possible mechanism underlying such interactions. They used three model:
Tumour growth modulated by two effector cell type, Tumour growth modulated by
effector cells and normal cells through competition for resources, and tumour growth
modulated by effector cells and cytokines. The interactions between cancer cells, ef-
fector cells, and cytokines (especially IL-2) can explain long-term tumour relapse.
Finally, In the four equations model, the authors add a new equation to the model of
three equations. This extra equation describe, for example the dynamics of a cytokine
concentration, or the dynamics of chemokine concentration. They show two examples,
Two types of cells and two types of cytokines, and three type of cells and one cytokine
or chemokine. These model indicate that including the effects of the additional com-
ponent of the tumour microenvironment does not lead to any new behaviour. The
patterns are similar to those obtained with three-equation models. exponential growth
of tumour cells, oscillatory growth, or oscillatory decay. This suggests that the most
essential mechanisms have already been captured with three equations.
The Models of Bellomo et al.
Bellomo and Delitala (2008) reviewed the mathematical kinetic theory of active parti-
cles applied to the modelling of the very early stage of cancer phenomena, specifically
mutations, onset, progression of cancer cells, and their competition with the immune
system. The mathematical theory described the dynamics of large systems of inter-
acting entities whose microscopic state includes not only geometrical and mechanical
variables, but also specific biological functions. Applications of this model are focused
of complex biological system where two scales at the levels of genes and cells interact
generating the heterogeneous onset of cancer phenomena, and the analysis refers to the
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derivation of tissue level models from underlying description at the lower scales. The
modelling aspects of the interactions with lower and higher scale have been treated.
The authors consider a biological system viewed as a complex network of various
interacting subsystems, each of them expressing a well defined function. The state
of each subsystem is described at a specific scale, molecular, cellular or tissue. The
overall representation within each subsystem, labelled by the subscript i, is statically
described by the distribution functions:
fi = fi(t,u) : [0,T ]×Du→ R+, i= 1, ...,n
over the microscopic state u ∈Du of the active particles. By definition, dni = fi(t,u)du
denotes the number of active particles, which at time t, are in the element [u,u+du] of
the space of microscopic state.
Gross average quantities can be computed, when these function are obtained by so-
lution of the resultant equations. For instant, the local number density is calculated,
under suitable integrability assumptions on fi, as follows:
vi =
∫
Du
fi(t,u)du,
with the following quantities:
ai = a[ fi](t) =
∫
Du
u fi(t,u)du
and
Ai = A[ fi](t) =
a[ fi](t)
vi(t)
have been called, respectively, activation and the activation density. These quantities
represent, respectively, the overall activity of the cells per unit volume and their mean
activity.
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The overall evolution of the system is caused by interactions. Specifically, the follow-
ing phenomena (interactions), focused on cancer modelling, are considered:
• Stochastic modification of the microscopic state of genes or cells due to binary
interactions with other cells of the same or different populations. These inter-
actions are called conservative as they do not modify the number density of the
interacting populations.
• Genetic alteration of cells which may either increase the progression of tumour
cells or even generate, by clonal selection, new cells in a new population of
cancer cells with higher level of malignancy.
• Proliferation or destruction of cells due to binary interactions with other cells of
the same or of different populations.
• External actions, either therapeutical actions or other external agents, which
modify the distribution function
Also the authors defined the probability density destributions:
f = f (t,u) : [0,T ]×Du→ R+, i= 1, ...,n
and
φ = φ(t,u) : [0,T ]×Dv→ R+, i= 1, ...,n
over the microscopic states u ∈ Du and v ∈ Dv of the interacting entities regarded as
active particles.
The interaction scheme from the lower to the higher scale can be represented as fol-
lows:
[∂tφ = N[φ ,φ ]] → [∂t f =Mg[ f ,φ ]],
that corresponding to the following dynamics:
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• The evolution of the system at the lower scale is determined by the interaction
between genes among themselves and with the outer environment that is sup-
posed known.
• The evolution of the system at the higher scale is determined by the interaction
between active particles, of the population, among themselves and with particles
of the lower system that is obtained by solution of the evolution equation for
such a system.
Also, the authors reviewed when the cancer cells becomes relevant, various space phe-
nomena, including invasion and pattern formation due to aggregation and chemotaxis.
They added the space homogeneous description stochastic velocity jump process to the
model.
4.1.1 Other Immune-Tumour Interaction Models
Tumour cells are characterized by a large number of genetic and epigenetic events lead-
ing to the appearance of specific antigens (e.g. mutated proteins, under/over-expressed
normal proteins and many others) triggering reactions by the both the innate and the
adaptive immune system (Delves et al., 2006; Kindt et al., 2006; Pardoll, 2003; Swann
and Smyth, 2007; Yefenov, 2008; Szymanska, 2003; Garay and Lefever, 1978; Lefever
et al., 1992). These observations have provided a theoretical basis to the empirical hy-
pothesis of immune surveillance, i.e. that the immune system may act to eliminate tu-
mours (Ehrlich, 2009), only recently experimentally and epidemiologically confirmed
(Dunn et al., 2004). Of course, the competitive interaction between tumour cells and
the immune system involves a considerable number of events and molecules, and as
such is extremely complex. Thus, the kinetics of the interplay between tumour cells
and the immune system is strongly non-linear.
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Moreover, to describe fully the immuno-oncological dynamics, one has to take into
account a range of spatial phenomena. Indeed, the interplay between tumour cells and
the immune system is strongly influenced by the spatial mobility of both tumour cells
and cells of the immune system i.e. effector cells (Matzavinos et al., 2004). Indeed,
apart from the random motion of both types of cell, a prominent role is played by
chemoattraction of effector cells towards the tumour cells. Indeed, chemotactic motion
of immune system cells is a hallmark of the defence of the human body against “non-
self agents”, including tumours, since cells belonging to both the innate and adaptive
immune system are able to reach their targets thanks to the gradients of various kinds
of chemicals (Delves et al., 2006; Keener and Sneyd, 2003), e.g. inflammation-related
substances produced by tumour cells. Thus, chemotaxis is of paramount importance in
the interplay between tumours and the immune system, since it influences the control
of tumour growth and also the immune surveillance.
However, besides temporal and spatial non-linearities, another important point to stress
is that the structure of the above-mentioned interactions is also characterized by a se-
ries of evolutionary phenomena. As is self-evident, the immune system is not able
to eliminate all neoplasms. In other cases, a dynamic equilibrium may also be estab-
lished, such that the tumour may survive in a so-called “dormant state” (Koebel et al.,
2007; Chaplain and Matzavinos, 2006; d’Onofrio, 2005, 2007), which is undetectable.
Until recently this was largely inferred from clinical data, but Koebel et al. (2007)
have been able to show experimentally, through an ad hoc mouse model, that adaptive
immunity can maintain an occult cancer in an equilibrium state. It is quite intuitive
that this equilibrium can be disrupted by sudden events affecting the immune system.
Indeed, if disease-related impairments of the innate and adaptive immune systems, or
immuno-suppressive treatments preceding organ transplantations occur, then tumour
regrowth occurs (Dunn et al., 2004; Stewart and Abrams, 2008). This has been shown
both by mouse models and through epidemiological studies (Dunn et al., 2004; Stewart
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and Abrams, 2008).
However, there is a major class of causes of disruption of the equilibrium that are not
related to immuno-suppression. Indeed, over a long period of time Dunn et al. (2004),
a neoplasm may develop multiple strategies to circumvent the action of the immune
system (Pardoll, 2003; Dunn et al., 2004), which may allow it to recommence growing
(Dunn et al., 2004; d’Onofrio, 2007) into clinically apparent tumours (Koebel et al.,
2007), which theoretically can reach their maximum carrying capacity (d’Onofrio,
2007). From an ecological point of view, we could say that the tumour has adapted
to survive in a hostile environment, in which the anti-tumour immune response is ac-
tivated (Dunn et al., 2004; d’Onofrio, 2007). For example, the tumour may develop
mechanisms to grow and spread by reducing its immunogenicity (Pardoll, 2003; Dunn
et al., 2004). In other words, the immunogenic phenotype of the tumour is influenced
by the interaction with the immune system of the host. For this reason, the theory of the
interactions between a tumour and the immune system has been called immuno-editing
theory (Dunn et al., 2004).
An impressive body of research is accumulating on immuno-evasive strategies, and
a recent monograph Gabrilovich and Hurwitz (2008) has been devoted to some as-
pects of this fascinating subject and to its close relationship with the effectiveness of
immunotherapies. As far as the mathematical modelling of tumour and immune sys-
tem interactions is concerned, there are many papers in the current literature which
use deterministic models (Stepanova, 1980; Kuznetsov and Knott, 2001; Kogan et al.,
2010; Arciero et al., 2004; d’Onofrio, 2005, 2007, 2006, 2008; Kronick et al., 2010;
Kim et al., 2008; Lejeune et al., 2008) or stochastic models (Horsthemke and Lefever,
1977; Du and Mei, 2010; Caravagna et al., 2010; d’Onofrio, 2010), as well as mod-
els introduced by Bellomo based on the kinetic theories of nonlinear statistical me-
chanics (Bellomo et al., 2004; Bellomo and Delitala, 2008). The general approach of
Bellomo’s theory is based on the concept of changes of activities of both the tumour
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cells and the effector cells of the immune system after encounters between them. In
(d’Onofrio, 2007, 2008), the immuno-editing phenomenon was empirically modelled
by allowing the presence of slowly time-varying generic parameters in deterministic
models (with time-scales significantly longer than those typical of the tumour-immune
system interaction). Recently, in the framework of the above-mentioned kinetic ap-
proach, a generic model has been proposed for the learning ability of effector cells and
for the hiding of tumour cells (Bellomo, 2010).
4.2 General Cancer Modelling
In this section we will give a brief overview of some important mathematical models
of cancer invasion and tumour-induced angiogenesis.
Anderson et al. (2000) presented two types of mathematical model which describe the
invasion of host tissue by tumour cells. The first model focusses on the macro-scale
structure and considers the tumour as a single mass. This model consists of a system of
partial differential equations, describing the production and/or activation of degrada-
tive enzymes by the tumour cells, the degradation of the matrix and the migratory
response of the tumour cells. The second model focusses on the micro-scale (individ-
ual cell) level and uses a discrete technique. This technique enables one to examine
the implications of metastatic spread.
Chaplain and Lolas (2005) considered a mathematical model of cancer cell invasion
of tissue which focuses on the role of the plasminogen activation system. This model
consists of a system of reaction-diffusion-taxis partial differential equations describing
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the interactions between cancer cells, urokinase plasminogen activator (uPA), uPA in-
hibitors, plasmin and the host tissue. It focus of the modelling on the spatio-temporal
dynamics of the uPA system and how this influences the migratory properties of the
cancer cell through random motility, chemotaxis, and haptotaxis. The main achieve-
ment of this model is that fairly simple mathematical model representing the binding
interactions of the components of the plasminogen activation system coupled with cell
migration were able to capture the main characteristic effects of the system in cancer
progression and invasion.
Finally, Chaplain (1995) considered two mathematical models which describe different
aspects of solid tumour growth and development- angiogenesis and vascular growth. In
this paper, the model of Chaplain and Stuart (1993) was modified and improved quali-
tative results were obtained with simulations in one spatial dimension. Also the model
was extended to two spatial dimensions in order to take into account explicitly the key
features of angiogenesis of anastomosis and secondary sprout formation (branching).
In the second part of this paper, standard reaction-diffusion theory (turing-type mod-
els) was applied to a novel situation- that of the growth of solid tumours. It was shown
that the spatially heterogeneous patterns which arise in the case of a spherical geom-
etry may play a part and help to explain certain observed phenomenon in carcinoma
and multicell spheroids.
Chapter 5
Evasion of Tumours from the Control
of the Immune System: A
Consequence of a Brief Encounter
5.1 Introduction
In this chapter, based on the concept introduced by Dunn et al. (2004) that the im-
mune system has the ability of sculpting the phenotype of a tumour cell, we propose
a cell-centred semi-mechanistic approach aimed at describing a possible immunologi-
cally realistic kinetic mechanism through which immuno-evasion begins. Since there
is strong experimental evidence that type, density and location of CTLs are predic-
tive of the clinical outcome of some neoplasms, such as colorectal tumours (Galon
et al., 2006), and since we are interested in the long-time dynamics, here we shall
deal with the interplay of a neoplasm with CTLs. In our model, we suppose that the
tumour cells that survive an attack by CTLs have a probability of acquiring (through
mutations or even by epigenetic changes) a phenotype that is more resistant to future
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attacks by CTLs. In turn, at each new encounter with a CTL, this resistance can be
increased further, and after a finite number of encounters a complete or maximal resis-
tance to specific immunity is acquired. Moreover, specific spatial effects may be linked
to the immuno-evasion of neoplasms. Indeed, recently Vianello et al. (2006) showed
experimentally that tumour cells can produce chemicals that act as chemo-repellors
for CTLs. We integrate these experimental findings in our model by permitting in
the range of features defining the increasingly resistant tumour cell phenotypes an in-
creasing ability to produce such chemorepulsive substances. These two bio-theoretical
hypotheses, although new, are in line with the general schema of tumour cell escape
from the immune response. Indeed, as stressed by Stewart and Abrams (2008), tu-
mour cells may escape from immune control through two general mechanisms: (a)
mechanisms that involve the secretion of soluble factors; (b) mechanisms that are de-
pendent on the contact between the tumour cells and the effectors and that are aimed
at reducing antigen recognition/adhesion and apoptotic resistance. Given the current
experimental knowledge the above mentioned factors are primarily aimed - apart from,
in many cases, their mitogenic action - at inducing the emergence of immunosuppres-
sive networks (Kim et al., 2007). In our present model, the factors, in line with the
animal model by Vianello et al. (2006), are chemicals that repel CTLs.
5.2 The Mathematical Model
Since we are modelling a situation where immuno-evasion of the tumour cells is not
considered, the interplay between tumour cells and tumour-infiltrating cytotoxic-T-
lymphocytes can be modelled as shown in figure 4.1. We develop the work of Matza-
vinos et al. (2004), by assuming that a proportion of the tumour cells that survive an
encounter with a CTL are more resistant to any future attacks by CTLs. Consequently,
the phenotypic properties of these new “enhanced” tumour cells will be different from
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Figure 5.1: Schematic diagram of the extended local lymphocyte-cancer cell interac-
tions
those of the “naive” tumour cells. Specifically, we make the additional assumptions:
• their probability of being killed (previously the parameter p) is smaller
• their probability of being recognized and also of forming a complex with a CTL
(embedded in the parameter k+) is smaller
Moreover, we shall also assume that the recruitment rate of CTLs stimulated by the
presence of the complexes is also smaller. We denote the initial naive tumour cells by
T0(t) and the non-naive tumour cells by Ti, where i stands for the number of previous
encounters with the CTLs. We assume that the fitness of tumour cells increases up to a
maximum number of encounters N, implying that we consider in total 1+N “classes”
of tumour cells, T0,T1, . . . ,TN .
The new kinetic relationships of our model are illustrated in figure 5.1 and are charac-
terized by the following new groups of parameters:
• the rate of formation of complexes [ETi]: k+i . We assume that k+i is constant or
decreasing with index i, with k+N ≥ 0;
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• the probability that a tumour cell of the i-th class is killed: pi. We assume that
pi is decreasing with index i, with pN ≥ 0;
• the probability of transition Ti → Ti+1 to the state i: ϑi. We assume that ϑi is
increasing for 0≤ i≤ N−1. Since we have assumed N classes of tumour cells,
ϑN = 0.
As far as the temporal dynamics of the tumour cells, CTLs and complexes is concerned,
once again using the Law of Mass Action, the kinetic scheme of figure 5.1 can be
translated into the following system of ordinary differential equations:
∂T0
∂ t
= −k+0 ET0+ k−C0+(1−θ0)(1− p0)kC0
∂Ti
∂ t
= −k+i ETi+θi−1(1− pi−1)kCi−1+(k−+ k(1−θi)(1− pi))Ci
∂Cl
∂ t
= k+l ETl− (k−+ k)Cl
∂E
∂ t
= −E(
N
∑
j=0
k+j Tj)+(
N
∑
j=0
k−C j)+(
N
∑
j=0
kp jC j)
(5.1)
where i= 1, ...,N, and l = 0, ...,N.
However, not only the temporal but also the spatio-temporal properties of the “fitter”
tumour cells are likely to be different from those of the baseline tumour cells. Namely:
• the production rates of chemoattractants stimulated by a complex CTL+ non
naive tumour cell’ is assumed to be smaller than that of the naive cells
• since recently Vianello et al. (2006) showed in an animal model that tumours
produce chemicals that repels the CTLs, here we assume that those chemorepel-
lors are produced by the non-naive cells
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• the non-naive cells might be repelled by chemorepellors produced by CTLs
In the following, we provide the full equations for all variables, including the spatial
components. As mentioned in the previous section, we have assumed the model of
Matzavinos et al. (2004) as our baseline model.
Spatiotemporal Dynamics of the Tumour Cells
Following Matzavinos et al. (2004), we assume that the tumour growth may be de-
scribed by a logistic law, and that the tumour cells migrate randomly. Thus, it follows
that the spatio-temporal dynamics of the naive tumour cells T0 is as follows:
∂T0
∂ t
=
random motion︷ ︸︸ ︷
DT0∇
2T0 +
logistic growth︷ ︸︸ ︷
r1T0(1−β1
N
∑
j=0
Tj)−
local kinetics︷ ︸︸ ︷
k+0 ET0+(k
−+ k(1−θ0)(1−b0))C0
and the dynamics of the non-naive cells Ti is given by:
∂Ti
∂ t
=
random motion︷ ︸︸ ︷
DTi∇
2Ti +
logistic growth︷ ︸︸ ︷
r1Ti(1−β1
N
∑
j=0
Tj)
−
local kinetics︷ ︸︸ ︷
k+i ET0+(k
−+ k(1−θi)(1−bi))Ci+ kθi−1(1− pi−1)Ci−1
where i= 1, . . . ,N.
Spatiotemporal Dynamics of the CTLs
Considering the CTLs, as in Matzavinos et al. (2004), both random and chemotactic
motion of these cells is included. However, as previously discussed, an additional
type of motility is included due to the postulated onset of “negative taxis” due to the
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production of a chemorepellor ρ by the non-naive tumour cells (Vianello et al., 2006).
This results in the following equation:
∂E
∂ t
=
random motility︷ ︸︸ ︷
DE∇2E −
chemotaxis︷ ︸︸ ︷
χ(α)∇.(E∇α)+
chemo−repulsion︷ ︸︸ ︷
A(ρ)∇.(E∇ρ)+
supply︷ ︸︸ ︷
sh(x)+
proli f eration+recruitment︷ ︸︸ ︷
f
N
∑
j=0
q jC j
g+
N
∑
j=0
Tj
−
decay︷︸︸︷
d1E −
local kinetics︷ ︸︸ ︷
E(
N
∑
j=0
k+j Tj)+(
N
∑
j=0
k−C j)+(
N
∑
j=0
kp jC j)
The recruitment rate of the CTLs, E, stimulated by the complexes C j is embedded in
the rate constant q j, which, as a consequence, must be decreasing with the index j,
with qN ≥ 0. The external influx of CTLs is, for the sake of the simplicity, modelled
as sh(x), where h(x) is a Heaviside function, taken to be zero over a given subregion
of the domain of interest cf. Matzavinos et al. (2004). In other words, we assume
that there is a subdomain where lymphocytes are not naturally present and which is
penetrated by CTLs only thanks to diffusion and chemotaxis.
Chemoattractant
The spatiotemporal dynamics of the chemoattractant α produced by the complexes is
given by
∂α
∂ t
=
di f f usion︷ ︸︸ ︷
D2∇2α −
decay︷︸︸︷
δ1α +
production︷ ︸︸ ︷
(
N
∑
j=0
pi jC j)
where we assume that the production rate constant pii is decreasing with index i, with
piN ≥ 0, since we assume that complexes between CTLs and non-naive tumour cells
are less and less able to produce such a chemoattractant.
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Chemorepellor
Adapting the experimental findings by Vianello et al. (2006) to our framework, we
suppose that the non-naive tumour cells produce a chemical that repels the CTLs and
whose concentration ρ is governed by the equation
∂ρ
∂ t
=
di f f usion︷ ︸︸ ︷
Dρ∇2ρ −
decay︷︸︸︷
δ2ρ +
production︷ ︸︸ ︷
(
N
∑
j=0
w jTj)
where the production rate constants wi are such that: w0 = 0 (absence of production
for naive tumour cells) and
w1 < w2 < · · ·< wN .
Tumour cell-CTL Complexes
Following Matzavinos et al. (2004), we assume that the motility of the complexes is so
small that it can be neglected:
∂Cl
∂ t
=
local kinetic︷ ︸︸ ︷
k+l ETl− (k−+ k)Cl
where l = 0, . . . ,N.
5.3 Boundary and Initial Conditions
We initially consider the model in a fixed 1-dimensional domain [0,xa] and close the
system by applying appropriate boundary and initial conditions. As far as the bound-
ary conditions are concerned, zero-flux boundary conditions are imposed on all state
variables (apart from C): E, α , ρ and Ti, i = 0, ...,N. These boundary conditions
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are appropriate for the tumour-immune dynamics we are considering. For example, in
BCL1 lymphomas of the spleen tumour cells are spatially contained in the lymph tissue
of the spleen, an elongated organ that, in mice, is characterized by a very strong base-
ment membrane, which is only broken when the tumour cells switch to an “invasive
phenotype”. Since here we are concerned with earlier stage dynamics of tumour cells
in a dormant state evading the CTLs, it follows that the zero-flux boundary conditions
are adequate for our particular model.
As far as the initial conditions are concerned, we assume an initial front of naive tu-
mour cells encountering a front of CTLs, resulting in the formation of C0 complexes.
We suppose that initially there are no non-naive tumour cells and hence no complexes
involving them. No chemicals are initially present in the spatial domain. These as-
sumptions yield:
E(x,0) =
 0, if 0≤ x≤ l,Ea(1− exp(−1000(x− l)2)), if l < x≤ xa.
T0(x,0) =
 Ta(1− exp(−1000(x− l)
2)), if 0≤ x≤ l,
0 if l < x≤ xa.
Ti(x,0) = 0,∀x ∈ [0,xa].
C0(x,0) =
 0, if x /∈ [l− ε, l+ ε],Ca exp(−1000(x− l)2), if x ∈ [l− ε, l+ ε].
Ci(x,0) = 0,∀x ∈ [0,xa].
α(x,0) = 0,∀x ∈ [0,xa].
59
ρ(x,0) = 0,∀x ∈ [0,xa].
where
Ea =
s
d1
, Ta =
1
β1
, Ca = min(Ea,Ta), 0 < ε  1, i= 1, ...,N.
Note that Ea is the the baseline homogenous steady-state value of CTLs in the absence
of tumour cells, and that Ta is the the baseline homogenous steady-state value of the
naive cells in absence of CTLs.
5.4 Non-dimensionalisation
Before undertaking any computational simulations, we non-dimensionalise our model
(as well as the boundary and initial conditions) by adopting the following scaling:
i) space is scaled by adopting a reference value xa equal to the size of the domain in
consideration and we assume xa = 1 cm; time is rescaled relative to the diffusion rate
of CTLs by setting ta = x2aDE :
x¯=
x
xa
, t¯ =
t
ta
;
ii) cellular densities are rescaled relative to the maxima of the respective initial condi-
tions:
T¯i =
Ti
Ta
, E¯ =
E
Ea
, C¯i =
Ci
Ca
, i= 0, . . . ,N
iii) The concentrations of the chemoattractant and of the chemorepellor are rescaled
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relative to the baseline values αa and ρa respectively:
α¯ =
α
αa
, ρ¯ =
ρ
ρa
By omitting the bars, for the sake of simplifying the notation, the proposed model
becomes:
∂E
∂ t
= ∇2E− γ(α)∇(E∇α)+ξ (ρ)∇(E∇ρ)+η1
N
∑
j=0
q jC j
a+
N
∑
j=0
Tj
−E(
N
∑
j=0
ψ jTj)−σE
+k3(
N
∑
j=0
C j)+ k4(
N
∑
j=0
p jC j)+σh(x),
∂α
∂ t
= Dα∇2α−δαα+µα(
N
∑
j=0
pi jC j),
∂ρ
∂ t
= Dρ∇2ρ−δρρ+µρ(
N
∑
j=0
w jTj), (5.2)
∂T0
∂ t
= ∇2T0+ rT0(1−
N
∑
j=0
Tj)−φ0ET0+ k1C0+(1−θ0)(1− p0)k2C0,
∂Ti
∂ t
= ∇2Ti+ rTi(1−
N
∑
j=0
Tj)−φiETi+ k1Ci+θi−1(1− pi−1)k2Ci−1
+k2(1−θi)(1− pi)Ci,
∂Cl
∂ t
= ψlETl−λCl,
where:
r = r1ta φi = k+i Eata k1 =
k−Cata
Ta
a= gTa
λ = (k−+ k) ψi = k+i Tata k2 =
kCata
Ta
γ = αataχ(α)
η1 = f taTa σ = µota k3 = k
−ta µα = Cataαa
Dα = D2ta δα = δ1ta k4 = kta µρ = Tataρa
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After the non-dimensionalisation, the boundary conditions become (in 1-D):
∂E
∂x
(0, t) = 0,
∂E
∂x
(1, t) = 0,
∂α
∂x
(0, t) = 0,
∂α
∂x
(1, t) = 0,
∂ρ
∂x
(0, t) = 0,
∂ρ
∂x
(1, t) = 0,
∂Ti
∂x
(0, t) = 0,
∂Ti
∂x
(1, t) = 0,
which then imply, assuming some smoothness of the solution and the form of Ci equa-
tions, that
∂Ci
∂x
(0, t) = 0,
∂Ci
∂x
(1, t) = 0.
and the initial conditions take the form (again in 1-D):
E(x,0) =
 0, if 0≤ x≤ l,(1− exp(−1000(x− l)2)), if l < x≤ 1,
α(x,0) = 0,∀x ∈ [0,1]
ρ(x,0) = 0,∀x ∈ [0,1]
T0(x,0) =
 (1− exp(−1000(x− l)
2)), if 0≤ x≤ l,
0, if l < x≤ 1,
Ti(x,0) = 0,∀x ∈ [0,1],
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C0(x,0) =
 0, if x /∈ [l− ε, l+ ε],exp(−1000(x− l)2), if x ∈ [l− ε, l+ ε],
where : l=0.1, and ε = 0.01.
Ci(x,0) = 0,∀x ∈ [0,1].
5.5 Parameter Values: Baseline Set
To carry out the computational simulations of the proposed model, we used the baseline
parameter set reported in Matzavinos et al. (2004), since these were all estimated from
experimental data on murine B-cell Lymphoma BCL1, which is an animal model for
the study of tumour dormancy (Uhr and Marches, 2001). In addition to this baseline
set, we used the migration parameters proposed in Chaplain and Matzavinos (2006).
Thus, the complete parameter set is the following:
s= 1.36×104 day−1cells cm−1 f = 0.2988×108 day−1cells cm−1
g= 2.02×107 cells cm−1 k+0 = 1.3×10−7 day−1cells−1 cm
k− = 24 day−1 k = 7.2 day−1
p0 = 0.9997 r1 = 0.18 day−1
β1 = 2×10−9 cells−1 cm d1 = 0.0412 day−1
DE = 10−6 cm2 day−1 χ = 1.728×106 cm2 day−1 M−1
DTi = 10
−6 cm2 day−1 D2 = 8×10−3cm2 day−1
Hence, from the experimental data above, the non-dimensional values of parameters
becomes:
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γ = 1.728×102 η1 = 5.976×104 ψ0 = 6.5×107
σ = 4.12×104 k3 = 2.4×107 k4 = 7.2×106
Dα = 8×103 δα = 1.115×104 µαpi0 = 104
r = 1.8×105 φ0 = 4.29×104 k1 = 1.584×104
k2 = 4.752×103 λ = 3.12×107 a= 4.04×10−2
As far as the spatiotemporal dynamics of the chemorepellor is concerned, we as-
sume that its diffusion coefficient and decay rate is the same as the chemokine α i.e.
Dρ = Dα , δρ = δα , µρ = µα , and ξ = γ .
Concerning the transitions Ti→ Ti+1, we assume that they are a linear function of i:
θi = θ0+(θMAX −θ0) iN−1 , i= 0, . . . ,N−1,
θN = 0,
θMAX = 10θ0,
and that their baseline value is sufficiently small: 10−5 ≤ θ0 ≤ 10−3.
The probability pi that a tumour cell of class Ti is lethally hit is given by:
pi = p0+(pN− p0) iN ,
where :
0≤ pN < p0.
Concerning the rates k+i , we assume either that they are constant or that they are lin-
early decreasing with k+N = 0:
64
k+i = k
+
0
(
1− i
N
)
.
The production rate of chemoattractant is also assumed to vary linearly:
pii = pi0
(
1− i
N
)
with:
pi0 = 20−3000 molecules cells−1 min−1,
We suppose that the chemorepellor is produced via a mechanism of “threshold gener-
ation”, i.e. only after a sufficient number of encounters, yielding:
wi =

0, if 0≤ i≤ N∗,
wMAX i−N∗N−N∗ , N∗ < i≤ N,
(5.3)
where we can assume:
wMAX ≈ pi0.
5.6 Computational Simulation Results
In addition to the baseline parameter set detailed in the previous section, in the follow-
ing sections all our computational simulations were performed assuming values for
key parameters associated with the encounter of CTLs and tumour cells as follows:
θ0 = 10−4, pN ∈ {0,0.5,0.75,0.9997}, k+0 = 1.3×10−7
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and k+i may be either constant or linearly decreasing, with k
+
N = 0.
Since the average lifespan of a chimeric mouse is three years, and since we are inter-
ested in assessing the possibility (and spatio-temporal modality) of the onset of immu-
noevasion of a tumour, all simulations (unless stated) represent an interval of length
1100 days ≈ 3 years.
5.6.1 Spatially Homogenous Case
In this first set of simulations, we set all the spatial components of the model to zero
and consider only the reaction kinetics in order to ascertain whether the primary mech-
anism of evasion can be purely temporal. All simulations suggest that our model, with
the parameter assumptions and values we used, is able to reproduce the onset of im-
munoevasion in a biologically realistic time-frame.
Figure 5.2 shows the plots of the growth of the tumour cell population over time where
the killing probability at the last stage is zero, i.e. pN = 0, and k+i = constant =
1.3× 10−7. We observe that if N = 4 the onset of evasion is at t ≈ 200 days, i.e. the
tumour remains dormant for 200 days, which is a long period of time. On the contrary,
if N = 10 then the immunoevasion is delayed even further, with onset at t ≈ 500 days.
Figure 5.3 shows the plots of the growth of the tumour cell population over time where
the killing probability at the last stage is not zero but it is only halved, i.e. pN =
0.5, and as in the previous figure, k+i = constant = 1.3× 10−7. Also in this case the
immunoevasion is reproduced and takes place, respectively, at t ≈ 425 days for N = 4
and at t ≈ 950 days for N = 10.
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Figure 5.2: Plots showing the growth of the tumour cell population over time in the
case where the spatial components of the model (i.e. all diffusion, taxis terms) have
been set to zero. The plots show that the tumour can evade the immune system for
either approximately 200 days or approximately 500 days depending on the parameter
N. Parameter values: pN = 0 and k+i = constant = 1.3× 10−7 and: N = 4 (solid
line) and N = 10 (dashed lines). The red lines represent the population T0, the blue
lines represent the summed populations T1+ ...+TN , and the black lines represent the
summed populations T0+ ...+TN . Time t is in days.
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Figure 5.3: Plots showing the growth of the tumour cell population over time in the
case where the spatial components of the model (i.e. all diffusion, taxis terms) have
been set to zero. The plots show that the tumour can evade the immune system for
either approximately 400 days or approximately 950 days depending on the parameter
N. Parameter values: pN = 0.5 and k+i = constant = 1.3× 10−7 and: N = 4 (solid
line) and N = 10 (dashed lines). The red lines represent the population T0, the blue
lines represent the summed populations T1+ ...+TN , and the black lines represent the
summed populations T0+ ...+TN . Time t is in days.
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Figure 5.4: Plots showing the growth of the tumour cell population over time in the
case where the spatial components of the model (i.e. all diffusion, taxis terms) have
been set to zero. The plots show that the tumour can evade the immune system for
either approximately 850 days or approximately 1900 days depending on the parameter
N. Parameter values: pN = 0.75 and k+i = constant = 1.3× 10−7 and: N = 4 (solid
line) and N = 10 (dashed lines). The red lines represent the population T0, the blue
lines represent the summed populations T1+ ...+TN , and the black lines represent the
summed populations T0+ ...+TN . Time t is in days.
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Figure 5.5: Plots showing the growth of the tumour cell population over time in the
case where the spatial components of the model (i.e. all diffusion, taxis terms) have
been set to zero. The plots show that the tumour can evade the immune system for
either approximately 250 days or approximately 550 days depending on the parameter
N. Parameter values: pN = 0.75 and k+i are linearly decreasing functions and: N = 4
(solid line) and N = 10 (dashed lines). The red lines represent the population T0, the
blue lines represent the summed populations T1+ ...+TN , and the black lines represent
the summed populations T0+ ...+TN . Time t is in days.
Figure 5.4 shows the plots of the growth of the tumour cell population over time where
the killing probability at the last stage is pN = 0.75, and as in the previous figure,
k+i = constant = 1.3×10−7. These results are different from the previous two cases.
Here the immunoevasion takes place in the lifespan of the mouse only for the case
N = 4. This suggests that in absence of changes in the parameter k+i : i) the late stages
Ti are the most important to determine the onset of the evasion; ii) due to the finite
lifespan of chimeric mice and to the slow rate of the transitions, the immunoevasion
process requires that the maximum ability of genetic or epigenetic changes in a tumour
cell upon complexing with a CTL (embedded in the transition probability whose max-
imum, we recall, is at i= N−1), is reached in a small number of encounters.
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Figure 5.6: Plots showing the growth of the tumour cell population over time in the
case where the spatial components of the model (i.e. all diffusion, taxis terms) have
been set to zero. The plots show that the tumour can evade the immune system for
either approximately 350 days or approximately 850 days depending on the parameter
N. In this case however, the initial population T0 is eradicated. Parameter values:
pi = constant = 0.9997 and k+i are linearly decreasing functions and: N = 4 (solid
line) and N = 10 (dashed lines). The red lines represent the population T0, the blue
lines represent the summed populations T1+ ...+TN , and the black lines represent the
summed populations T0+ ...+TN . Time t is in days.
Figure 5.5 shows the growth of the tumour cell population over time where the param-
eter pN = 0.75, but in this case the parameters k+i are linearly decreasing with k
+
N = 0.
We notice the following differences from the previous case: i) here the onset of immu-
noevasion is for N = 4 at t ≈ 250 days, i.e. it is considerably accelerated; ii) there is
the onset of immunoevasion (at t ≈ 550 days) also for N = 10. Thus, this simulation
suggests that the role of the decrease of the probability that a tumour cell is recognized
by a CTL is important for the timing of the onset of immunoevasion. Moreover, the
decrease of the parameters k+i alone is sufficient to induce immunoevasion, as sug-
gested in the simulations shown in figure 5.6, where pi = constant = 0.9997 and k+i
are linearly decreasing.
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Figure 5.7: Plots showing the growth of the tumour cell population over time in the
case where the spatial components of the model (i.e. all diffusion, taxis terms) have
been set to zero. The plots show that the tumour can evade the immune system for
either approximately 200 days or approximately 400 days depending on the parameter
N. Parameter values: pN = 0 and k+i are linearly decreasing functions and: N = 4
(solid line) and N = 10 (dashed lines). The red lines represent the population T0, the
blue lines represent the summed populations T1+ ...+TN , and the black lines represent
the summed populations T0+ ...+TN . Time t is in days.
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However, as shown in figure 5.7, if pN = 0, then the addition of the mechanism of
decreasing k+i does not accelerate the onset of immunoevasion to such a degree with
respect to the baseline case of constant k+i shown in the previous figure 5.2.
Finally, comparing the results shown in all the figures we have examined in this section,
we note that
Max(T0)<Max(T1+ · · ·+TN)
holds in the cases where k+i is decreasing. Moreover, Max(T0) seems to be a decreas-
ing function of pN . These results might be explained as follows: the decrease of the
competition between all the tumour cells and the immune system embedded in the de-
crease of the parameters k+i , might shift the ‘internal’ competition between the naive
and the non-naive tumour cells.
5.6.2 Spatiotemporal Model
1-Dimensional Domain
Before we present the computational simulation results of the new model in this chap-
ter, in figures 5.8 and 5.9 we plot the spatial distribution of tumour cells and CTLs,
respectively, in the baseline case of the absence of immunoevasive mechanisms.
Figure 5.8 shows the spatial distribution of tumour cell density within the tissue at
times 100, 400, 700, and 1100 days. These results illustrate the basic spatiotemporal
dynamics of the tumour cell density induced by its interplay with the distribution of
CTLs i.e. a gradual transition between a front of tumour cells to a train of solitary-like
traveling waves slowly invading the tissue, finally creating a spatially heterogeneous
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Figure 5.8: Plots showing the spatial distribution of tumour cells within the tissue at
times corresponding to 100, 400, 700, and 1100 days, respectively, in the baseline case
of absence of the immunoevasive mechanism described in this chapter. This corre-
sponds to the results of Matzavinos et al. (2004).
and time-changing (through irregular temporal oscillations) distribution. Similarly, fig-
ure 5.9 shows the corresponding plots of the CTL density.
Figure 5.10 shows the spatial distribution of tumour cell density within the tissue
at times 100, 400, 700, and 1100 days where the parameters pN = 0.75 and k+i =
constant. These results show that if we include the immunoevasive mechanism with a
decreased value for the parameter pN , we obtain a process that is identical to the base-
line case for most of the time. Indeed, basically the first three plots of this figure are
identical to those of figure 5.8. However, after the onset of the evasion, the tumour cell
density distribution changes significantly as can be seen in the left part of the domain.
From these observed differences, we may say that in this modelling framework the
74
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0
5
10
15
20
25
30
t = 100
distance into tissu
Ly
m
ph
oc
yte
 d
en
sit
y
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0
10
20
30
40
50
60
70
t = 400
distance into tissu
Ly
m
ph
oc
yte
 d
en
sit
y
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0
10
20
30
40
50
60
70
80
t = 700
distance into tissu
Ly
m
ph
oc
yte
 d
en
sit
y
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0
5
10
15
20
25
30
35
40
45
50
t = 1100
distance into tissu
Ly
m
ph
oc
yte
 d
en
sit
y
Figure 5.9: Plots showing the spatial distribution of CTLs within the tissue at times
corresponding to 100, 400, 700, and 1100 days, respectively, in the baseline case of
absence of the immunoevasive mechanism described in this chapter. This corresponds
to the results of Matzavinos et al. (2004).
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Figure 5.10: Plots showing the distribution of tumour cell density within the tissue
at times corresponding to 100, 400, 700, and 1100 days respectively. These plots
illustrate the spatiotemporal onset of immunoevasion. The final plot at t = 1100 should
be compared to the equivalent plot in figure 5.8. Parameter values pN = 0.75 and
k+i = constant. Solid line with chemorepellor, dashed line without (i.e. ξ = 0). The
red lines represent the population T0, The blue lines represent the summed population
T1+ ...+TN , and the black lines represent the summed population T0+ ...+TN .
effect of immunoevasion on the spatio-temporal dynamics is characterized by a return
to a spatially homogeneous steady-state. This transition to the new spatial regimen is
illustrated in more detail by the “time-slices” shown in figure 5.11.
Finally, we note that the predicted effect on the tumour cells spatial distribution of the
induction of chemorepulsion of CTLs is not detectable if we consider the total density
of all tumour cells. However it is noticeable if we consider the density of T0 versus the
density of T1+ · · ·+TN (see the fourth plot of figure 5.10).
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Figure 5.11: Plots showing detailed changes in the spatial distribution of all tumour
cells
N
∑
j=0
Tj within the tissue over time in the case of immunoevasion. Parameter values
pN = 0.75 and k+i = constant.
Figures 5.12 and 5.13 show the corresponding density of CTLs in the tissue. Note that
after the onset of immunoevasion, corresponding to the newly reformed invasive front
of tumour cells at a high density, the density of CTLs is close to zero.
Figure 5.14 shows the spatial distribution of tumour cell density within the tissue at
times 100, 400, 700, and 1100 days in the case where the parameters pN = 0.75 and
k+i are decreasing such that k
+
N = 0. Due to the acceleration of the immunoevasion
caused by the synergy existing between the variability of pi and k+i , the plots in this
figure are substantially different from those in the baseline case in figure 5.8 and also
with respect to the plots in figure 5.10. Indeed, in this case the spatio-temporal dis-
tribution of the tumour cell density is far more regular, and by t = 1100 days almost
all of the tissue has been invaded by the tumour cells close to their maximum density.
Moreover, here in large regions of the domain we have T0 < T1+ · · ·+TN , which is the
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Figure 5.12: Plots showing the distribution of CTLs within the tissue at times corre-
sponding to 100, 400, 700, and 1100 days respectively. These plots illustrate the spa-
tiotemporal onset of immunoevasion. The final plot at t = 1100 should be compared to
the equivalent plot in figure 5.9. Parameter values pN = 0.75 and k+i = constant. Solid
line with chemorepellor, dashed line without (i.e. ξ = 0).
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Figure 5.13: Plots showing detailed changes in the spatial distribution of CTLs within
the tissue over time in the case of immunoevasion. Parameter values pN = 0.75 and
k+i = constant.
opposite of the previous case, where the naive tumour cells T0 were prevalent. Finally,
figure 5.14 illustrates the fact that the distributions of naive vs non-naive tumour cells
are “mirror-images” of one another and they are complementary, since their sum is a
homogeneous front.
In figure 5.15 we show the differential effect of chemorepulsion on the various classes
of tumour cells. The plots show the total number Ai(t) of cells in each classes, i.e.
Ai(t) =
∫ 1
0
Ti(x, t)dx,
over time, as well as, in the last plot, the grand-total A1(t)+ · · ·+AN(t). The effect of
the chemorepulsion on each sub-population Ai is striking, although overall it is globally
compensated (see the last plot).
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Figure 5.14: Plots showing the distribution of tumour cell density within the tissue
at times corresponding to 100, 400, 700, and 1100 days respectively. These plots
illustrate the spatiotemporal onset of immunoevasion. Parameter values pN = 0.75 and
k+i are decreasing such that k
+
N = 0. Solid line with chemorepellor, dashed line without
(i.e. ξ = 0). The red lines represent the population T0, The blue lines represent the
summed population T1+ ...+TN , and the black lines represent the summed population
T0+ ...+TN .
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Figure 5.15: Plots showing the effects of chemorepulsion on the total number of spa-
tially distributed classes of tumour cells. Plots of the total number of cells Ai(t) =∫ 1
0 Ti(x, t)dx. Panels: (a) A0, (b) A1, (c) A2, (d) A3, (e) A4, and (f)
4
∑
j=0
A j(t). Solid line
with chemorepellor, dashed line without (i.e. ξ = 0). Time is measured in days.
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Figure 5.16: Plots showing the distribution of tumour cell density within the tissue
at times corresponding to 100, 400, 700, and 1100 days respectively. These plots
illustrate the spatiotemporal onset of immunoevasion. Parameter values pN = 0.5 and
k+i are constant. Solid line with chemorepellor, dashed line without (i.e. ξ = 0). The
red lines represent the population T0, The blue lines represent the summed population
T1+ ...+TN , and the black lines represent the summed population T0+ ...+TN .
Figure 5.16 shows the distribution of tumour cell density within the tissue at times
corresponding to 100, 400, 700, and 1100 days respectively with parameter values
pN = 0.5 and k+i = constant = k
+
0 . Note that in this case, although pN = 0.5, probably
due to the constancy of k+i , in large parts of the space the number of naive cells exceeds
the rest of the classes of other tumour cells, i.e. T0 > T1 + · · ·+TN . Note that at the
end of the average lifespan of the mouse, the tissue is invaded to a large extent but to
a lesser extent that in the case where pN = 0.5 and k+N = 0. Figure 5.17 shows a more
detailed evolution of the tumour cell density by presenting the “time-slices” from t = 0
to t = 1100. Figure 5.18 shows the corresponding distribution of CTL density.
Finally, figure 5.19 shows the distribution of tumour cell density within the tissue at
82
0
0.2
0.4
0.6
0.8
1
0
200
400
600
800
1000
0
0.5
1
Distance in tissue
Time in days
T 0
+.
..+
T N
 d
en
sit
y
Figure 5.17: Plots showing detailed changes in the spatial distribution of all tumour
cells
N
∑
j=0
Tj within the tissue over time in the case of immunoevasion. Parameter values
pN = 0.5 and k+i = constant.
times corresponding to 100, 400, 700, and 1100 days respectively when the parame-
ters pN = 0.5 and k+N = 0. This figure summarizes well the important role of the two
parameters pN and k+N in shaping the spatio-temporal distribution of tumour cells. In-
deed, the parameter k+N appears to accelerate the onset and the velocity of propagation
of the invasive front, and moreover it also differentially shapes T0 and T1+ · · ·+TN .
2-Dimensional Domain
In this section, we undertake computational simulations for our model in the absence of
any ‘taxis’ on a two-dimensional domain i.e. we did not included the chemotaxis and
chemorepulsion terms. Moreover, here we also considered a constant influx of CTLs.
The simulations were performed using MATLAB enhanced with the tool COMSOL
Multiphysics which uses a finite-element approach to solve PDEs. As extension of the
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Figure 5.18: Plots showing the distribution of CTLs within the tissue at times cor-
responding to 100, 400, 700, and 1100 days respectively. These plots illustrate the
spatiotemporal onset of immunoevasion. Parameter values pN = 0.5 and k+i are con-
stant. Solid line with chemorepellor, dashed line without (i.e. ξ = 0).
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Figure 5.19: Plots showing the distribution of tumour cell density within the tissue
at times corresponding to 100, 400, 700, and 1100 days respectively. These plots
illustrate the spatiotemporal onset of immunoevasion. Parameter values pN = 0.5 and
k+N = 0. Solid line with chemorepellor, dashed line without (i.e. ξ = 0). The red lines
represent the population T0, The blue lines represent the summed population T1+ ...+
TN , and the black lines represent the summed population T0+ ...+TN .
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1-D settings, we considered the rectangular domain:
D= [0,1]× [0,1]⊂ R2
with zero-flux boundary conditions. The initial conditions are:
T0(x,y) = T (x,y,0) = exp(−100((x−0.5)2+(y−0.5)2)),
E0(x,y) = E(x,y,0) = 1− exp(−100((x−0.5)2+(y−0.5)2)),
with the other variables being set to zero initially.
Once again in figures 5.20, 5.21 we first of all plot the spatial distribution of tumour
cells and CTLs, respectively, in the baseline case of the absence of immunoevasive
mechanisms (cf. figures 5.8 and 5.9).
Following the 1-dimensional results, figures 5.22 and 5.23 show the spatial distribution
of, respectively all tumour cells and of CTLs in the case pN = 0.75 and constant k+i .
Figures 5.24 and 5.25 show the spatial distribution of, respectively, all tumour cells
and of CTLs in the case pN = 0.75 and kN = 0.
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Figure 5.20: Plots showing the spatial distribution of the total tumour cell density
(
N
∑
j=0
Tj) within the tissue in a 2-dimensional spatial domain at times corresponding
to 100, 400, 700, and 1100 days, respectively, in the baseline case of absence of the
immunoevasive mechanism described in this chapter.
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Figure 5.21: Plots showing the spatial distribution of the CTL density within the tissue
in a 2-dimensional spatial domain at times corresponding to 100, 400, 700, and 1100
days, respectively, in the baseline case of absence of the immunoevasive mechanism
described in this chapter.
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Figure 5.22: Plots showing the spatial distribution of the total tumour cell density
(
N
∑
j=0
Tj) within the tissue in a 2-dimensional spatial domain at times corresponding to
100, 400, 700, and 1100 days, respectively. These plots illustrate the spatiotemporal
onset of immunoevasion. Parameter values pN = 0.75 and k+i is constant.
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Figure 5.23: Plots showing the spatial distribution of the CTL density within the tissue
in a 2-dimensional spatial domain at times corresponding to 100, 400, 700, and 1100
days, respectively. These plots illustrate the spatiotemporal onset of immunoevasion.
Parameter values pN = 0.75 and k+i is constant.
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Figure 5.24: Plots showing the spatial distribution of the total tumour cell density
(
N
∑
j=0
Tj) within the tissue in a 2-dimensional spatial domain at times corresponding
to 100, 300, 350, 400, 700, and 1100 days respectively. These plots illustrate the
spatiotemporal onset of immunoevasion. Parameter values pN = 0.75 and k+N = 0.
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Figure 5.25: Plots showing the spatial distribution of the CTL density within the tis-
sue in a 2-dimensional spatial domain at times corresponding to 100, 300, 350, 400,
700, and 1100 days respectively. These plots illustrate the spatiotemporal onset of
immunoevasion. Parameter values pN = 0.75 and k+N = 0.
92
5.7 Discussion and Conclusions
In this chapter we have presented a novel mathematical model of the immune re-
sponse to cancer, focussing on the specific spatio-temporal response of cytotoxic T-
lymphocytes to tumour cells. We have developed and extended ideas originally formu-
lated by Matzavinos et al. (2004) by proposing a possible kinetic mechanism leading to
tumour evasion from the immune control. Our model is based on the key concept that a
tumour cell which survives the formation of a complex with a cytotoxic T-lymphocyte
can develop, with a given probability, an increased probability of surviving further
attacks by CTLs. We do not specify whether this so-called ‘increased resistance’ is
genetic or epigenetic. Indeed, from a kinetic point of view, this is immaterial. How-
ever, in order to experimentally validate the hypothesis, this distinction would be of
paramount relevance.
In this work we have dealt with the spatio-temporal interplay between tumours and a
specific immune response from CTLs. We chose this approach because of the exper-
imental evidence on the relevance of CTLs in determining tumour dormancy or the
evasion of many important tumours such as melanomas, ovarian carcinomas and col-
orectal carcinomas, where the presence of infiltrating lymphocytes is a useful prognos-
tic marker (Galon et al., 2006; Zitvogel et al., 2006). However, tumour immunoevasion
from dormancy is a multi-faceted phenomenon. We stress here that by no means do we
think that ours is an exhaustive theoretical treatment of a such complex phenomenon.
We have built our model based on the tumour dormancy mathematical model of Matza-
vinos et al. (2004) and Chaplain and Matzavinos (2006), where parameters were fitted
to experimental animal (mouse) data. However, embedding the proposed evolution-
ary mechanism in a more complex setting, where a more detailed description of both
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adaptive and innate immunity is included, should lead to results qualitatively similar
to those illustrated here.
Our simulations suggest that the proposed mechanism is able to mimic various dynam-
ics of immunoevasion during the lifespan of a mouse. We have also highlighted the
differential spatiotemporal contributions to evasion due, respectively, to: i) a decrease
in the probability pi of being lethally hit; ii) a decrease in the probability, embedded in
k+i , that a tumour cell is recognized by a CTL. In particular, our model suggests that
a decrease in the parameters pi is needed to produce evasion, which does not occur in
the case where pi remains constant at its baseline level inferred from the experimental
data. However, the role of the parameters k+i is important since it can greatly acceler-
ate the simulated process. Moreover, our computational simulations also showed that
the proposed mechanism can also deeply affect the spatial patterning of the tumour. In
particular, our model suggests that to have a uniform invasion profile for the tumour
cells necessitates also having a decrease in the recognition rate, embedded in the pa-
rameters k+i . These parameters also differentially shape the spatial distribution of the
various classes of tumour cells.
Concerning the possible chemorepulsion of CTLs, our computational simulation re-
sults showed that, in our biological settings, although it does not affect the spatiotem-
poral dynamics of the total number of tumour cells, it has a remarkable influence on the
spatio-temporal distribution of the different individual classes of tumour cells. Further
analysis is needed to ascertain if, with different parameters, the effect of this factor can
be different, and in order to understand the behaviour in the current setting.
As far as the key ‘immuno-evasion-related’ parameters such as θi, pi, and k+i are con-
cerned, we were not able to fit them with experimental data (apart, of course, from the
values for p0 and k+0 , from Matzavinos et al. (2004); Chaplain and Matzavinos (2006))
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because in the literature, to the best of our knowledge, immuno-editing is only illus-
trated by means of qualitative clinical or molecular experimental findings. In particu-
lar, no immuno-evasion-related tumour growth data are available. Indeed, a complete
experimental kinetic study of the adaptive evasion from tumour dormancy allowing,
for example, the plotting of tumour growth curves would currently be very difficult to
undertake. Thus we hope that this theoretical work may contribute to triggering such
experimental investigations, which would allow us to validate our model.
From a theoretical point of view, our model, although detailed and focused on a very
specific aspect of immuno-oncology, and on some very specific mechanisms, is con-
ceptually in line with the general theories by Bellomo (Bellomo et al., 2004; Bellomo
and Delitala, 2008; Bellomo, 2010). Indeed, here also the changes of activities of cells
upon encounters between tumour cells and effectors cells of the immune system are
central in determining the dynamics of the system.
In this work we essentially were interested in the basic facts of the immune response
to tumours. However, a number of immunotherapies have been proposed and also the-
oretically investigated (see d’Onofrio (2005); Arciero et al. (2004); Kim et al. (2008)
and references therein). We believe that both the experimental results concerning im-
munoevasion of tumours and the theoretical findings we have proposed here might
have some implication of interest in clinics. More in general, we share the opinion of
Zitvogel et al. (2006), who stressed that recent progress in immuno-oncology have not
influenced the way anticancer therapies are conceived and applied in clinics.
The model that was proposed here has to be understood as a detailed model at the
level of the kinetics of the cellular populations of a possible mechanism that might
enable tumour cells to evade from the control of adaptive immunity. The various spe-
cific (and tumour-dependent) strategies deployed by those cells in order to reach their
aim, are phenomenologically described by means of the model of the dependence of
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the various parameters on the classes of tumour cells, as well as in the macroscopic
modelling of the chemorepulsion. This is a first step in a research effort for a more
complete description of tumour cell immunoevasion, which will include the detailed
modelling of the biological mechanisms underlying those and other specific evasion
strategies. Thus, given the complex network of interplaying between inter-cellular and
intra-cellular signalling, and given the various temporal scales (from the rapid dynam-
ics of the intracellular pathways involved, to the relatively slow growth of a tumour,
up to the very slow onset of immunoevasion) as well as the spatial ones (from indi-
vidual cells to visible neoplasms), a more detailed model will have to be multiscale.
This will involve a wide array of computational tools, from those typical of computa-
tional biology and bioinformatics, to more classical analytical and numerical methods
of statistical mechanics and mathematical physics.
Chapter 6
A Mathematical Model of the Innate
and Adaptive Immune Response to
Cancer
6.1 Introduction
In this chapter, we develop a novel, comprehensive model of the interplay between
a tumour and both the innate and the cellular part of the adaptive immune system.
Our aim is of to assess the role of the kinetic and spatial parameters in influencing
the outcome of this interplay: tumour suppression, tumour evasion or transition to a
dormant state.
In order to be as realistic as possible, we shall modify and integrate two of the few
existing spatiotemporal models of tumour-immune system interplay:
• The Owen-Sherratt model (Owen and Sherratt, 1997), focused on the initial
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phases of the growth of a tumour, when it interacts mainly with the innate im-
mune system
• The Matsavinos-Kuznetsov-Chaplain model (Matzavinos et al., 2004), which
focused on the later stages of development of a tumour, when it interacts mainly
with the adaptive immune system
We shall also take into account the model by de Pillis et al. (2005). These models are
characterized by both a good degree of reproduction of the main features in immunon-
cology, and also for the accurate choice of the parameter values. As will be shown
in the following sections, the development of the model does not only require one to
simply “cut-and-paste” the above models and merge them: a series of modifications
is also needed. One of the major changes is that we include macrophages, which not
only can engulf and eliminate tumour cells, but also present antigens to the adaptive
immune system.
6.2 The Mathematical Model
The State Variables
The state variables of our PDE model will be the spatial densities of the various cell
type and the concentrations of the various chemical involved. We give here the com-
plete list with some overview description:
• T : tumour cells. In absence of the immune response they proliferate with logis-
tic growth. In the presence of the immune response, they may: i) be digested
by macrophages, with no possibility of survival; ii) be induced to apoptosis by
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Natural Killer cells (NK); iii) form short-lived complexes with the CTLs, which
try to kill the tumour cells;
• M0: macrophages that have never encountered tumour cells. Thus they are un-
able to present specific antigens of the tumour in order to study the adaptive
immune system;
• C0M: complexes formed by an M0 and by a tumour cell. They have a non-null
loss rate (due to the toxic chemicals contained in a tumour cell, which can kill the
macrophage) that is quite low. Usually, indeed, the macrophage survives (and
becomes an M1 cell). The tumour cell, once engulfed by an M0, never survives;
• M1: a macrophage that has encountered n ≥ 1 times a tumour cell. It has the
same features of an M0, but it also “presents” the antigens of the engulfed tumour
cells to the adaptive immune system;
• C1M: complexes formed by an M1 and by a tumour cell. Their behaviour is similar
to those of C0M complexes;
• AM: concentration of the chemoattractant produced by tumour cells and that
attracts the macrophages;
• N: natural killer cells. They induce the apoptosis of tumour cells. Their be-
haviour is similar to that of CTLs, but NKs belongs to the innate immune sys-
tem;
• CN : complexes formed by a tumour cell and a natural killer cell;
• AN : concentration of the chemoattractant produced by tumour cells and that
attracts the natural killers;
• En: naive T cells. If stimulated by antigen presenting cells (= M1) they transform
to CTLs;
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• E: cytotoxic T lymphocytes (CTLs);
• C: complexes formed by a CTL and a Tumour cell;
• AE : concentration of the chemokine attracting CTLs, which is produced by com-
plexes C.
The equation for the chemoattractant AM
The tumour cells produce a chemical that attracts the macrophages:
∂tAM = D4∇2AM−δ3AM+P1T, (6.1)
where D4 is the diffusion coefficient, δ3 is the degradation rate constant, and P1 is the
production rate constant.
The equation for the macrophages M0
Unlike Owen and Sherratt (1997) and given the different timescales of cell-cell inter-
actions and proliferations, here we do not suppose that macrophages may significantly
proliferate, so that their kinetics is given by:
∂tM0 = D2∇2M0−χ1∇
(
M0∇AM
)
−δ1M0−KM(AM)TM0+q(AM), (6.2)
where D2 is the diffusion coefficient of macrophages (equal for both classes), χ1 is
the chemotactic coefficient for macrophages (equal for both classes), δ1 is the death
rate coefficient for macrophages (equal for both classes), q(AM) > 0 is the influx rate
of macrophages - we consider this as a linear function of the chemoattactant concen-
tration as in Owen and Sherratt (1997): q(AM) = q0 (1+σAM), and KM(AM)TM0 is
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the rate of formation of C0M complexes. The rate coefficient KM(AM) depends on the
chemoattractant AM. We may model it as a linear function as in Owen and Sherratt
(1997) KM(AM) = k0AM.
The equation for the complexes C0M
The equation describing the dynamics of the complexes C0M is given by the following
equation:
∂tC0M = D3∇
2C0M−δ2C0M+KM(AM)TM0−β1C0M, (6.3)
where D3 is the diffusion coefficient for the complexes, δ2 is the loss rate (due to the
death of the macrophage), and β1C0M is the transition rate: C
0
M→ ‘digested’ Tumour cell+
M1, where a macrophage M0 after the encounter with the tumour cells puts the antigens
on its surface, so becoming an M1 macrophage cell that is able to present the antigens
to the naive CTL cells.
The equation for the complexes C1M
The equation describing the dynamics of the complexes C1M is similar to the equation
(6.3):
∂tC1M = D3∇
2C1M−δ2C1M+KM(AM)TM1−β1C1M (6.4)
only here β1C0M is the rate of returning to the state of non-complexed M
1:
C1M→ ‘digested’ Tumour cell+M1
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The equation for the macrophages M1
The equation describing the spatiotemporal dynamics of M1 is given by:
∂tM1 =D2∇2M1−χ1∇
(
M1∇AM
)
−δ1M1−KM(AM)TM1+q(AM)+β1C0M+β1C1M,
(6.5)
where β1C0M is the influx rate from the “un-complexing” of complexes C
0
M. The
macrophages now have contacted tumour cells at least once, and they have ‘exposed’
on their own surface the specific antigens of the killed tumour cell. +β1C0M is the influx
rate from the un-complexing of complexes C1M.
The equation for the naive and activated Cytotoxic T Lymphocytes
Extending the non-spatial model of Moore and Li (2004) (where the amount of antigen
presenting cells is considered proportional to the number of tumour cells) we have that
the dynamics of naive CTLs is given by:
∂tEn = D7∇2En−χ3∇(En∇AE)+Sn(x)−µnEn− γ(M1)En (6.6)
where Sn(x) is a baseline production rate of naive CTLs (concentrated in the lymph
nodes), D7 ≥ 0 is a diffusion coefficient of the naive CTLs, χ3 ≥ 0 is a chemotactic co-
efficient of the naive CTLs, µn is a loss rate coefficient of the naive CTLs, and γ(M1)En
is a macrophage-stimulated activation rate, where γ(M1) is an increasing function of
M1 with γ(0)≥ 0. For example: γ(M1) = aM11+bM1 .
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Finally, the equation for the activated CTLs is given by:
∂tE = R(x,T )+ γ(M1)En+
fC
g+T
+D7∇2E−χ3∇(E∇AE) (6.7)
−µE− k+TE+ k−C+ kpC,
where R(x,T )≥ 0 is the influx rate of CTLs, γ(M1)En is the influx of activated CTLs
due to the encounter of naive CTLs with M1 cells, fC/(g+T ) is the rate of recruit-
ment and proliferation stimulated by the presence of the tumour, µ is the baseline death
rate of the CTLs, k+TE is the rate of forming T-CTLs complexes, k−C is the rate of
the transition C→ T +CTL, and p is the probability that a tumour cell dies so that
kpC is the rate of the transition C→ Dead tumour cell +CTL. The above equations
(6.6)-(6.7) have an inherent problem: naive CTLs reside in lymph nodes and not di-
rectly to the site of the tumour. To take into account this process, we should include a
chemical produced by naive CTLs, which attracts the M1 macrophages. This first ap-
proach is ‘exact’, and does not require an enormous effort to be included in the model.
However, it might make the simulations more difficult since it needs a (elementary
maybe) description of the geometry of lymph nodes. In anycase, denoting by An this
chemoattractant, one has:
∂tAn = D8∇2An−δ6An+P3En, (6.8)
and the equation for the M1 macrophages has to be augmented by including a term
describing chemotactic motion towards the naive CTLs:
∂tM1 =−χ4∇
(
M1∇An
)
(6.9)
+D2∇2M1−χ1∇
(
M1∇AM
)
−δ1M1−KM(AM)TM1+q(AM)+β1C0M+β1C1M,
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The equation for the Tumour Cell-CTL Complexes
∂tC = k+TE− kdC− k−C− kC, (6.10)
where kdC is the loss rate of complexes (i.e. the rate of the transitionC→ Dead tumour cell +
Dead CTL ), and kC = kpC+ k(1− p)C is the sum of the rates of the transitions:
C→ Dead tumour cell +CTL (occurring with probability p) and C→ tumour cell+
Dead CTL (occurring with probability 1− p).
The equations of AE
The complex produces a chemokine that attracts the activated (and the non-activated)
CTLs:
∂tAE = D8∇2AE −δ6AE +P4C, (6.11)
where D8 is the diffusion coefficient, δ6 is the degradation rate constant, and P4 is the
production rate constant.
The equation for the Natural Killer Cells
The equation describing the spatiotemporal dynamics of NK is given by:
∂tN =D5∇2N−χ2∇(N∇AN)+q(AN)−δ4N−KN(AN)TN+γNCN+hwCN+pi(T )N,
(6.12)
where γNCN is the influx rate from the “un-complexing” of complexesCN , and pi(T ) is
the natural killer recruitment term. For example: pi(T ) = g1T
2
h1+T 2
.
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The equation of AN
The tumour cells produce chemicals that attract the Natural Killer cells:
∂tAN = D6∇2AN−δ5AN+P2T, (6.13)
where D6 is the diffusion coefficient, δ5 is the degradation rate constant, and P2 is the
production rate constant.
The equation for the Tumour Cell-NK Complexes
∂tCN = h+TN−hdCN−h−CN−hCN , (6.14)
where hdCN is the loss rate of complexes, i.e. the rate of the transition
CN→ Dead tumour cell + Dead N , and hCN = hwCN+h(1−w)CN is the sum of the
rates of the transitions: CNK → Dead tumour cell +N (occurring with probability w)
and CN → tumour cell+ Dead N (occurring with probability 1−w).
The Equation for the Tumour Cells
Considering that the tumour in the absence of the immune response grows with a lo-
gistic rate, which is not substantially perturbed by the immune system, and considering
that the tumour cells have the possibility of random motion with diffusion coefficient
D1, and using the previous assumptions on the interplay of the tumour with the immune
system, one has:
∂tT = rT (1− TC1 )+D1∇
2T (6.15)
−kM(AM)T (M0+M1)−h+TN+h−CN+h(1−w)CN− k+TE+ k−C+ k(1− p)C.
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Thus the full mathematical model is:
∂tT = D1∇2T + rT (1− TC1 )− k0AMT (M
0+M1)−h+TN+h−CN
+h(1−w)CN− k+TE+ k−C+ k(1− p)C,
∂tM0 = D2∇2M0−χ1∇(M0∇AM)−δ1M0− k0AMTM0+q0(1+σAM),
∂tC0M = D3∇
2C0M−δ2C0M+ k0AMTM0−β1C0M,
∂tM1 = D2∇2M1−χ1∇(M1∇AM)−χ4∇(M1∇An)−δ1M1− k0AMTM1
+q0(1+σAM)+β1C0M+β1C
1
M,
∂tC1M = D3∇
2C1M−δ2C1M+ k0AMTM1−β1C1M,
∂tAM = D4∇2AM−δ3AM+P1T,
∂tN = D5∇2N−χ2∇(N∇AN)+q0(1+σAN)−δ4N−KNNT + γNCN
+hwCN+
g1T 2
h1+T 2
N,
∂tCN = h+TN−hdCN−h−CN−hCN , (6.16)
∂tAN = D6∇2AN−δ5AN+P2T,
∂tEn = D7∇2En−χ3∇(En∇AE)+SN(x)−µNEn− aM11+bM1En,
∂tAn = D8∇2An−δ6An+P3En,
∂tE = D7∇2E−χ3∇(E∇AE)+R(x,T )+ aM11+bM1En+
fC
g+T
−µE
−k+TE+ k−C+ kpC,
∂tC = k+TE− kdC− k−C− kC,
∂tAE = D8∇2AE −δ6AE +P4C.
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Boundary and initial conditions
We consider the model in a fixed 1-dimensional domain [0,1] and close the system
by applying appropriate boundary and initial conditions. As far as the boundary con-
ditions are concerned, zero-flux boundary conditions are imposed on all state variables.
The initial conditions are given by:
T (x,0) =
 1, if x ∈ [l− ε, l+ ε],0, if x /∈ [l− ε, l+ ε].

M0(x,0)
M1(x,0)
N(x,0)
En(x,0)
E(x,0)

=
 0, if x ∈ [l− ε, l+ ε],0.2, if x /∈ [l− ε, l+ ε].
where l = 0.5 and ε = 0.01, and zero initial conditions for the remaining variables.
6.3 Parameter values
To carry out the computational simulations of the proposed model, we used the values
have been reported in the literature. In Table (6.1) we summarise these parameter
values with supporting references. Also we suppose D5 = D2, D6 = D4, χ2 = χ1,
χ4 = χ3, h− = k−, h= k, hd = 0, kd = 0, δ5 = δ3, P2 = P1, and P3 = P4.
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Table 6.1: A summary of the dimensional parameter estimates
Parameter Dimensional estimate Supporting references
D1 10−6cm2day−1 (Matzavinos et al., 2004)
r 0.18 day−1 (Matzavinos et al., 2004)
C1 0.5×109cells cm−1 (Matzavinos et al., 2004)
k0 8.64 cm3 day−1 M−1 (Owen and Sherratt 1997)
h+ 7.13×10−10 day−1 (de Pillis et al., 2006)
β1 3.45×10−2 day−1 (Owen and Sherratt 1997)
w 0.5 -
k+ 1.3×10−7day−1cells−1cm (Matzavinos et al., 2004)
χ1 2×106 cm2 day−1 M−1 (Owen and Sherratt 1997)
k 7.2 day−1 (Matzavinos et al., 2004)
p 0.9997 (Matzavinos et al., 2004)
D2 8.64×10−7 cm2 day−1 (Owen and Sherratt 1997)
k− 24 day−1 (Matzavinos et al., 2004)
δ1 1.728×10−2 day−1 (Owen and Sherratt 1997)
q0 3.46×106 cm−3 day−1 (Owen and Sherratt 1997)
σ 58×1010 M−1 (Owen and Sherratt 1997)
D3 4.32×10−7 cm2 day−1 (Owen and Sherratt 1997)
δ2 0.086 day−1 (Owen and Sherratt 1997)
D4 0.1728 cm2 day−1 (Owen and Sherratt 1997)
P1 4.32×10−20 M cm3 day−1 (Owen and Sherratt 1997)
δ3 3.457×10−1 day−1 (Owen and Sherratt 1997)
KN 7.13×10−10 day−1 (de Pillis et al., 2005)
γN 24 day−1 (de Pillis et al., 2005)
h1 2.02×107 cells (de Pillis et al., 2005)
g1 4.98×10−1 day−1 (de Pillis et al., 2005)
SN 0.073 cells day−1 µl (Moore and Li 2004)
δ4 4.12×10−2 day−1 (de Pillis et al., 2005)
D7 10−6cm2day−1 (Matzavinos et al., 2004)
χ3 1.728×106 cm2day−1 M−1 (Matzavinos et al., 2004)
a 10−5 day−1 cells−1 µl (Moore and Li 2004)
µn 0.04 day−1 (Moore and Li 2004)
R 1.36×104 day−1cells cm−1 (Matzavinos et al., 2004)
g 2.02×107 cells cm−1 (Matzavinos et al., 2004)
µ 0.0412 day−1 (Matzavinos et al., 2004)
f 0.2988×108day−1 cells cm−1 (Matzavinos et al., 2004)
b 10−2 cells−1 µl (Moore and Li 2004)
D8 8×10−3 cm2 day−1 (Matzavinos et al., 2004)
δ6 1.155×10−2 day−1 (Matzavinos et al., 2004)
P4 3.03×10−18 (Matzavinos et al., 2004)
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6.4 Linear Stability Analysis
We consider the system of ODEs of the underlying spatially homogeneous of model
(6.16):
∂tT = rT (1− TCC )− k0AMT (M
0+M1)−h+TN+h−CN
+h(1−w)CN− k+TE+ k−C+ k(1− p)C,
∂tM0 = −δ1M0− k0AMTM0+q0(1+σAM),
∂tC0M = −δ2C0M+ k0AMTM0−β1C0M,
∂tM1 = −δ1M1− k0AMTM1+q0(1+σAM)+β1C0M+β1C1M,
∂tC1M = −δ2C1M+ k0AMTM1−β1C1M,
∂tAM = −δ3AM+P1T,
∂tN = q0(1+σAN)−δ4N−KNNT + γNCN+hwCN+ ggT
2
hh+T 2
N,
∂tCN = h+TN−hdCN−h−CN−hCN , (6.17)
∂tAN = −δ5AN+P2T,
∂tEn = SN(x)−µNEn− aM11+bM1En,
∂tE = R(x,T )+
aM1
1+bM1
En+
fC
g+T
−µE− k+TE+ k−C+ kpC,
∂tC = k+TE− kdC− k−C− kC,
Using the parameter values described in Table (6.1), it is straightforward to show that
there are two positive steady states; free tumour steady state (healthy state) and small
tumour steady state (dormant state).
By linearising about each steady state, we find that the first steady state is unstable,
and the second steady state is stable.
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6.5 Computational Simulation Results
6.5.1 Spatially Homogenous Case
In this first set of simulations, we set all the spatial components of the model to zero
and consider only the reaction kinetics. Figure 6.1 shows the plots of the tumour cell,
macrophage (M0,M1), natural killer, naive and activated CTLs. We observe that there
is a slowly damped oscillation in the behaviour of the tumour, natural killer and CTL
cells. Also we note that the solution converges to the second steady state where the
tumour size is small (dormant state).
In figures 6.2 and 6.3, we changed the values of q0 and δ4. This values of parameters
gave us two saddle steady states, one with free tumour and the second is with big value
of tumour. Also we have a close orbit (limit cycle). We take the time is 10000 days
to show the limit cycle. We note that the new shape of solutions with conserve the
oscillations.
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Figure 6.1: Plots showing the growth of the tumour cell population, macrophages M0,
macrophages M1, natural killer cells, naive CTLs and CTLs over time 2000 days in the
case where the spatial components of the model (i.e. all diffusion, taxis terms) have
been set to zero. The initial condition is taken close to the first steady state.
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Figure 6.2: Plots showing the growth of the tumour cell population, macrophages M0,
macrophages M1, natural killer cells, naive CTLs and CTLs over time 10000 days in
the case where the spatial components of the model (i.e. all diffusion, taxis terms) have
been set to zero, with q0 = 3.46×104 and δ4 = 4.12.
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Figure 6.3: Plots showing the solution of the ODE system between (a) macrophages
and tumour cells, (b) natural killer cells and tumour cells, and (c) CTLs and tumour
cells, with q0 = 3.46× 104 and δ4 = 4.12. The plots show there is limit cycle orbit
between the variables over time 10000 days.
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Figure 6.4: Plots showing the distribution of tumour cell density within the tissue at
times corresponding to 100, 400, 700, and 1100 days respectively.
6.5.2 Spatiotemporal Case
Now we present the computational simulation results of model (6.16) with the param-
eter values in Table (6.1). Figure 6.4 shows the spatial distribution of tumour cell
density within the tissue at time 100, 400, 700, and 1100 days . These results illustrate
that the tumour size is decreasing with time, and is then fixed at the steady state value.
Similarly figures 6.5 and 6.6 shows the macrophage density, the distribution of macrophages
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Figure 6.5: Plots showing the distribution of macrophage M0 cell density within the
tissue at times corresponding to 100, 400, 700, and 1100 days respectively.
M0 is similar to the distribution of macrophages M1.
Figure 6.7 shows the distribution of the natural killer cells. The behaviour of the solu-
tion is similar to the behaviour of the solution for the tumour cells up to time 400 days.
However, then the shape of the profile of the natural killer cells changes. Figure 6.8
shows the naive CTL density. We note the solution of the En reaches the steady state
value after a short time.
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Figure 6.6: Plots showing the distribution of macrophage M1 cell density within the
tissue at times corresponding to 100, 400, 700, and 1100 days respectively.
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Figure 6.7: Plots showing the distribution of natural killer cell density within the tissue
at times corresponding to 100, 400, 700, and 1100 days respectively.
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Figure 6.8: Plots showing the distribution of naive CTL cell density within the tissue
at times corresponding to 100, 400, 700, and 1100 days respectively.
Finally, figure 6.9 shows the distribution of CTL cell density, again the shape of solu-
tion is close to the shape of the tumour solution with different values.
Figure 6.10 shows the spatial distribution of tumour cell density within the tissue at
time 100, 400, 700, and 1100 days, with q0 = 3.456× 4 and δ4 = 4.12. We note the
size of tumour is different than the previous case (figure 6.4), in additional, we note
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Figure 6.9: Plots showing the distribution of CTL cell density within the tissue at times
corresponding to 100, 400, 700, and 1100 days respectively.
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Figure 6.10: Plots showing the distribution of tumour cell density within the tissue at
times corresponding to 100, 400, 700, and 1100 days respectively. With q0 = 3.456×
104 and δ4 = 4.12.
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Figure 6.11: Plots showing the distribution of macrophage M0 cell density within the
tissue at times corresponding to 100, 400, 700, and 1100 days respectively. With
q0 = 3.456×104 and δ4 = 4.12.
that small clusters of tumour with time 700 days and new clusters of tumour appear
with time 1100 days.
Figures 6.11 and 6.12 show the spatial distribution of macrophage M0 and M1 cell den-
sity within the tissue at time 100, 400, 700, and 1100 days, with q0 = 3.456×104 and
δ4 = 4.12. This results illustrate the effect of the limit cycle for the behaviour of the
solution if we compare these results with pervious results in figures 6.5 and 6.6.
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Figure 6.12: Plots showing the distribution of macrophage M1 cell density within the
tissue at times corresponding to 100, 400, 700, and 1100 days respectively. With
q0 = 3.456×104 and δ4 = 4.12.
Figure 6.13 shows the spatial distribution of natural killer cell density within the tissue
at time 100, 400, 700, and 1100 days, with q0 = 3.456×104 and δ4 = 4.12. The size
of natural killer in this figure is smaller than the previous case (figure 6.7), and there is
drop in the middle at 1100 days because there is cluster of tumour in the same position
and at the same time.
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Figure 6.13: Plots showing the distribution of natural killer cell density within the
tissue at times corresponding to 100, 400, 700, and 1100 days respectively. With
q0 = 3.456×104 and δ4 = 4.12.
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Figure 6.14: Plots showing the distribution of naive CTL cell density within the
tissue at times corresponding to 100, 400, 700, and 1100 days respectively. With
q0 = 3.456×104 and δ4 = 4.12.
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Figure 6.15: Plots showing the distribution of CTL cell density within the tissue at
times corresponding to 100, 400, 700, and 1100 days respectively. With q0 = 3.456×
104 and δ4 = 4.12.
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Figures 6.14 and 6.15 show the spatial distribution of naive and active CTL cell density
within the tissue at time 100, 400, 700, and 1100 days, with q0 = 3.456× 104 and
δ4 = 4.12. Again there are oscillations in the solutions and a drop in the middle of
space at time 1100 days for the same reason as that for the natural killer cells. In
addition, the size of CTLs is bigger than the previous case (figure 6.9).
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6.6 Discussion and Conclusions
In this chapter we have presented a mathematical model of the interplay between a
tumour and both the innate and the cellular part of the adaptive immune system. We
have developed and extended the ideas originally formulated by Owen and Sherratt
(1997), Matzavinos et al. (2004), de Pillis et al. (2005).
In this first set of simulations, we set all the spatial components of the model to zero
and consider only the reaction kinetics, then we shows some spatio-temporal simu-
lations which explain the interplay between tumours and macrophages, natural killer
cells and cytotoxic T lymphocytes.
We observed that there is a slowly damped oscillation in the behaviour of the tumour,
natural killer and CTL cells. Also we note that the solution converges to the second
steady state where the tumour size is small (dormant state).
Also we found from the linear stability analysis for the model. there is two positive
steady states, the first (free tumour steady state i.e. healthy steady state) is saddle and
the second (small tumour steady state i.e. dormant state) is stable.
We changed the stability of this steady states by changed the parameters q0 and δ4,
where got two saddle positive steady states and the tumour values of the second steady
state become big, and the limit cycle still appears.
In the second set of simulations, we found the solution of model (6.16). Following
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to the ODE simulations we considered two cases, depending on the parameter values
such that the first case in like Table (6.1) and the second case is by change two pa-
rameters q0 and δ4. In the first case the solution tend to the positive steady state, and
the solution of macrophage M0 is similar to the solution of M1. The behaviour of the
solution of natural killer is similar to the behaviour of the solution for the tumour cells
up to time 400 days, then the shape of the profile of the natural killer cells changed.
The solution of the En reach the steady state value after a short time. The solution of
CTL again have the same shape of tumour solution with different values.
In the second case we got the different behaviour of solution because there is limit cycle
and oscillation in the shapes of solution and also the values of variables are changed.
Chapter 7
A Mathematical Model of Cancer
Invasion of Tissue with an Immune
Response
In this chapter we develop a mathematical model of cancer invasion of tissue in the
presence of an immune response. We base our cancer invasion model on that of Chap-
lain and Lolas (2005). This model describes invasive solid tumour growth and how
the interactions between cancer cells (C), urokinase plasminogen activator (uPA) (U),
plasminogen activator inhibitor-1 (PAI-1) (P), plasmin (M) and the extracellular matrix
(ECM) (V) may regulate tumour invasion and metastasis. We derive the new model by
including the immune response of effector cells (E) to this model, and we explain the
solution of this model for ODEs and PDEs (in 1 and 2 dimensional space). Further-
more, we discuss the stability of the steady states and compute the bifurcation analysis
for the parameters.
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7.1 Cancer Invasion Model
This model investigates the properties of the urokinase plasminogen activation system
and its role in cancer invasion and metastasis.
Cancer cells :- Following Chaplain and Lolas (2005) the “word equation” for the can-
cer cell density is :
(Rate of change of cell density)
= (random motility) - (chemotaxis due to uPA) - ( chemotaxis due to PAI-1)
-(haptotaxis due to V) + (proliferation)
+(extra proliferation due to uPA-cancer cells interactions)
thus the mathematical form of the above equation is:
∂C
∂ t
= DC
∂ 2C
∂x2︸ ︷︷ ︸
random motion
− ∂
∂x
( χCC
∂U
∂x︸ ︷︷ ︸
uPA−chemo
+ ζCC
∂P
∂x︸ ︷︷ ︸
PAI−1−chemo
+ξCC
∂V
∂x︸ ︷︷ ︸
V−hapto
)
+ φ13CU︸ ︷︷ ︸
proli f eration
+µ1C(1− CC0 )︸ ︷︷ ︸
proli f eration
,
where DC,χC,ζC,ξC,µ1,φ13 are the random motility, uPA-mediated chemotaxis, PAI-
1-mediated chemotaxis, V-mediated haptotaxis coefficients, the cancer cell prolifera-
tion rate and the cancer cell-surface receptors recycling rate respectively.
Extracellular matrix : The “word equation” for ECM is:
(Rate of change of ECM density)
= (degradation due to plasmin formation)+(proliferation)
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+ (indirect growth of V due to PAI-1/uPA binding)
- (neutralization due to PAI-1 inhibition)
thus the mathematical equation is :
∂V
∂ t
= − δVM︸ ︷︷ ︸
degradation
+ φ21UP︸ ︷︷ ︸
uPA/PAI−1
− φ22VP︸ ︷︷ ︸
PAI−1/V
+µ2V (1− VV0 )︸ ︷︷ ︸
proli f eration
,
where δ ,µ2,φ21,φ22, respectively the degradation rate, proliferation rate, production
rate of PAI-1/uPA binding and the counterbalancing of PAI-1 binding to V.
Urokinase plasminogen activator-uPA :- The “word equation” of uPA is :
(Rate of change of uPA concentration)
= (motion due to diffusion) + (production due to cancer cells)
- (removal due to PAI-1 inhibition)
- (removal due to binding to cancer cells)
thus the mathematical equation is :-
∂U
∂ t
= DU
∂ 2U
∂x2︸ ︷︷ ︸
di f f usion
− φ31PU︸ ︷︷ ︸
PAI−1/uPA
− φ33CU︸ ︷︷ ︸
uPA/cells
+ α31C︸︷︷︸
production
,
where DU ,α31,φ31,andφ33 are the uPA diffusion coefficient, rate of production by can-
cer cells, neutralization by PAI-1 inhibition and rate of binding to cell-surface receptors
(uPAR)
Plasminogen activator inhibitor-1 :- The plasminogen activator inhibitor-1 (PAI-1)
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conservation equation is similar to that of uPA considered above, and the “word equa-
tion” is :-
(Rate of change of PAI-1 concentration)
= (motion due to diffusion)
+ (production due to plasmin activator or cell secretion)
- (loss due to V binding)-(loss due to uPA binding)
thus the mathematical equation is :-
∂P
∂ t
= DP
∂ 2P
∂x2︸ ︷︷ ︸
di f f usion
− φ41PU︸ ︷︷ ︸
PAI−1/uPA
− φ42PV︸ ︷︷ ︸
PAI−1/V
+ α41M︸ ︷︷ ︸
production
,
where DP,α41,φ41,φ42 respectively the diffusion coefficient, the rate of production as
a result of plasmin formation, the neutralization rate by uPA binding and the neutral-
ization rate by V binding.
Plasmin :- The “word equation” of plasmin is :-
(Rate of change of plasmin concentration)
= (motion due to diffusion) + (production by cells)
- (loss due to uPA/PAI-1 binding) + (production due to PAI-1/V binding),
thus the mathematical equation is :-
∂M
∂ t
= DM
∂ 2M
∂x2︸ ︷︷ ︸
di f f usion
− φ51PU︸ ︷︷ ︸
PAI−1/uPA
+ φ52PV︸ ︷︷ ︸
PAI−1/V
+ φ53UC︸ ︷︷ ︸
uPA/cells
,
where DM is the plasmin diffusion coefficient, φ53 is the rate of production due to
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uPA/uPAR binding, φ52 is the rate of production due to PAI-1/V and φ51 is the inacti-
vation rate due to uPA inhibition by PAI-1.
Hence the dimensional system of equation describing the interactions of cancer cells,
ECM, uPA, PAI-1, and plasmin is :-
∂C
∂ t
= DC
∂ 2C
∂x2︸ ︷︷ ︸
random motion
− ∂
∂x
( χCC
∂U
∂x︸ ︷︷ ︸
uPA−chemo
+ ζCC
∂P
∂x︸ ︷︷ ︸
PAI−1−chemo
+ξCC
∂V
∂x︸ ︷︷ ︸
V−hapto
)
+ φ13CU︸ ︷︷ ︸
proli f eration
+µ1C(1− CC0 )︸ ︷︷ ︸
proli f eration
,
∂V
∂ t
= − δVM︸ ︷︷ ︸
degradation
+ φ21UP︸ ︷︷ ︸
uPA/PAI−1
− φ22VP︸ ︷︷ ︸
PAI−1/V
+µ2V (1− VV0 )︸ ︷︷ ︸
proli f eration
,
∂U
∂ t
= DU
∂ 2U
∂x2︸ ︷︷ ︸
di f f usion
− φ31PU︸ ︷︷ ︸
PAI−1/uPA
− φ33CU︸ ︷︷ ︸
uPA/cells
+ α31C︸︷︷︸
production
, (7.1)
∂P
∂ t
= DP
∂ 2P
∂x2︸ ︷︷ ︸
di f f usion
− φ41PU︸ ︷︷ ︸
PAI−1/uPA
− φ42PV︸ ︷︷ ︸
PAI−1/V
+ α41M︸ ︷︷ ︸
production
,
∂M
∂ t
= DM
∂ 2M
∂x2︸ ︷︷ ︸
di f f usion
− φ51PU︸ ︷︷ ︸
PAI−1/uPA
+ φ52PV︸ ︷︷ ︸
PAI−1/V
+ φ53UC︸ ︷︷ ︸
uPA/cells
.
In this chapter, we use the modification of this original model given by Andasari
et al. (2010) by removing the term (φ13CU) from the cancer equation, removing the
(−φ51PU) term from the plasmin equation, and adding the degradation term (−φ54M)
to plasmin equation.
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7.2 The Mathematical Model of Cancer Invasion in the
Presence of an Immune Response
In this section we include the immune response equation to the invasion model (7.1):
Effector cell :- The “word equation” for the effector cell density is:
(Rate of change of cell density)
= (random motility) + (proliferation) -(Immune response)
thus the mathematical form of above equation is:
∂E
∂ t
= DE
∂ 2C
∂x2︸ ︷︷ ︸
random motion
+rE(1− E
E0
)︸ ︷︷ ︸
proli f eration
− dEC
E+a︸ ︷︷ ︸
Immune response
,
where DE , is the random motility.
Also we change the proliferation term of cancer equation to get the close orbit between
cancer and effector solutions. This close orbit will give us oscillation for both cancer
and effector solution with time, therefore we getting the continuos interactions between
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cancer and effector cells. The Model (7.1) becomes:
∂E
∂ t
= DE
∂ 2E
∂x2︸ ︷︷ ︸
di f f usion
+rE(1− E
E0
)︸ ︷︷ ︸
proli f eration
− dEC
E+a︸ ︷︷ ︸
Immune response
,
∂C
∂ t
= DC
∂ 2T
∂x2︸ ︷︷ ︸
di f f usion
− ∂
∂x
( χCC
∂U
∂x︸ ︷︷ ︸
uPA−chemo
+ ζCC
∂P
∂x︸ ︷︷ ︸
PAI−1−chemo
+ξCC
∂V
∂x︸ ︷︷ ︸
V−hapto
)
+bC(1− hC
E+a
)︸ ︷︷ ︸
proli f eration
,
∂V
∂ t
= − δVM︸ ︷︷ ︸
degradation
+ φ31UP︸ ︷︷ ︸
uPA/PAI−1
− φ32VP︸ ︷︷ ︸
PAI−1/V
+µ2V (1− VV0 )︸ ︷︷ ︸
proli f eration
, (7.2)
∂U
∂ t
= DU
∂ 2U
∂x2︸ ︷︷ ︸
di f f usion
− φ41PU︸ ︷︷ ︸
PAI−1/uPA
− φ43TU︸ ︷︷ ︸
uPA/cells
+ α41T︸ ︷︷ ︸
production
,
∂P
∂ t
= DP
∂ 2P
∂x2︸ ︷︷ ︸
di f f usion
− φ51PU︸ ︷︷ ︸
PAI−1/uPA
− φ52PV︸ ︷︷ ︸
PAI−1/V
+ α51M︸ ︷︷ ︸
production
,
∂M
∂ t
= DM
∂ 2M
∂x2︸ ︷︷ ︸
di f f usion
+ φ62PV︸ ︷︷ ︸
PAI−1/V
+ φ63UT︸ ︷︷ ︸
uPA/cells
−φ64M︸ ︷︷ ︸
decay
.
Following Chaplain and Lolas (2005), we consider a spatial domainΩ= [0,2L], where
L=0.1 cm, and time with τ = L
2
D (where D represents a chemical diffusion coefficient
∼ 10−6cm2s−1).
The dependent variables and key parameters are rescaled thus:
t˜ =
t
τ
, x˜=
x
L
, E˜ =
E
E0
C˜ =
C
C0
, V˜ =
V
V0
, U˜ =
U
U0
, P˜=
P
P0
,
M˜=
M
M0
D˜E =
DE
D
, D˜C=
DC
D
, D˜U =
DU
D
, D˜P=
DP
D
, D˜M =
DM
D
,
χ˜C= χC
U0
D
, ξ˜C= ξC
V0
D
, ζ˜C= ζC
P0
D
, b˜= bτ, µ˜2 = µ2τ, d˜=
dC0τ
E0
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r˜= rτ a˜=
a
E0
h˜=
hC0
E0
δ˜ = δ
M0τ
V0
, ˜α31 =α31
C0
U0
τ, ˜α41 =α41
M0
P0
τ,
˜φ21 = φ21
U0P0
V0
τ, ˜φ22 = φ22P0τ, ˜φ31 = φ31P0τ. ˜φ33 = φ33C0τ
˜φ41 = φ41U0τ, ˜φ42 = φ42V0τ, ˜φ51 = φ51
U0P0
M0
τ, ˜φ53 = φ53
U0C0
M0
τ
Dropping the tildes for notational convenience, we obtain the non-dimensional system
of equations:
∂E
∂ t
= DE
∂ 2E
∂x2
+ rE(1−E)− dEC
E+a
,
∂C
∂ t
= DC
∂ 2T
∂x2
− ∂
∂x
(χCC
∂U
∂x
+ζCC
∂P
∂x
+ξCC
∂V
∂x
)+bC(1− hC
E+a
),
∂V
∂ t
= −δVM+φ31UP−φ32VP+µ2V (1−V ), (7.3)
∂U
∂ t
= DU
∂ 2U
∂x2
−φ41PU−φ43CU+α41C,
∂P
∂ t
= DP
∂ 2P
∂x2
−φ51PU−φ52PV +α51M,
∂M
∂ t
= DM
∂ 2M
∂x2
+φ62PV +φ63UC−φ64M.
where the non-dimensional values of parameter as in Table (7.1).
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Table 7.1: List of parameter values
Parameter Description Estimate Value
DE Random motility of effector cell 3.5×10−4
DT Random motility of tumour cell 3.5×10−4
DU Diffusion coefficient of uPA 2.5×10−3
DP Diffusion coefficient of PAI-1 3.5×10−3
DM Diffusion coefficient of plasmin 4.91×10−3
χT uPA-mediated chemotaxis coefficient 3.05×10−2
ξT PAI-1-mediated chemotaxis coefficient 2.85×10−2
ζT V-mediated haptotaxis coefficient 3.75×10−2
δ Degradation rate of V by plasmin 8.15
φ31 Production rate of PAI-1/uPA binding 0.75
φ32 Counterbalancing of PAI-1 binding V 0.55
µ Proliferation rate of V 0.85
φ41 Neutralization rate by PAI-1 inhibition binding 0.75
φ43 rate of binding to cell-surface receptors(uPAR) 0.3
α41 Production rate of uPA by cancer cells 0.215
φ51 Neutralization rate by uPA binding 0.75
φ52 Neutralization rate by V binding 0.55
α51 Production rate of PAI-1 by plasmin 0.5
φ62 Production rate due to PAI-1/V 0.11
φ63 Production rate due to uPA/uPAR binding 0.75
φ64 Decay rate of plasmin 0.5
h Constant 1.4
a Constant 0.1
b Proliferation rate of tumour 0.15
d Constant 0.95
r Proliferation rate of effector cell 0.8
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For boundary conditions, we impose zero-flux boundary conditions for all the variables
of the model at x = 0 and x = 2.
The initial conditions are given by:
E(x,0) =
 0, if 0≤ x≤ l,1− exp(−1000(x− l)2), if l < x≤ 2,
T (x,0) =
 1− exp(−1000(x− l)
2), if 0≤ x≤ l,
0, if l < x≤ 2,
V (x,0) = 1− 1
2
exp(
−x2
ε
), x ∈ [0,2] and ε > 0
U(x,0) =
1
2
exp(
−x2
ε
), x ∈ [0,2] and ε > 0
P(x,0) =
1
20
exp(
−x2
ε
), x ∈ [0,2] and ε > 0
M(x,0) = 0, x ∈ [0,2],
where ε = 0.01, l = 0.2 .
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7.3 Computational Simulation Results
7.3.1 Spatially Homogeneous Simulation
In this section, we set all spatial components of the model to zero and consider only
the reaction kinetics in order to compare between the behaviour of our model and
the model of Chaplain and Lolas (2005) with time 1000 (∼3000 hours), i.e. t=1 (∼3
hours). Figure 7.1 shows the dynamics of effector, tumour, ECM, uPA, PAI-1, and
plasmin over time. We observe that there is a regular oscillation for all species. This
occurs because there is a limit cycle between the effector cells and the tumour cells (see
section 7.4). Figure 7.2 shows the behaviour of the solutions of the model of Chaplain
and Lolas (2005). We observe the solution going to a stable steady state.
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Figure 7.1: Plots showing the growth of the tumour, effector, ECM, uPA, PAI-1, and
plasmin over time in the case where the spatial components of the model (i.e. all
diffusion, taxis terms) have been set to zero. The initial conditions were taken near the
non-trivial steady state.
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Figure 7.2: Plots showing the growth of the tumour, ECM, uPA, PAI-1, and plasmin
from Chaplain and Lolas (2005) over time in the case where the spatial components of
the model (i.e. all diffusion, taxis terms) have been set to zero. The initial conditions
were taken near the trivial steady state.
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Figure 7.3: Plots showing the distribution of tumour cell density, effector cell density,
and ECM within the tissue at times corresponding to 0, 1, 10, and 25 respectively. The
red lines represent the ECM, the blue lines represent the tumour, and the black lines
represent the effector cell. The dash line represents the results of Chaplain and Lolas
(2005), the solid line represents the model (7.1).
7.3.2 Spatiotemporal Simulations
In this section, we present the computational results of model (7.3). Figure 7.3 shows
the spatial distribution of effector cell, tumour cell, and ECM from t=0-25 with com-
paring between the results of model (7.3) and the model of Chaplain and Lolas (2005).
We note that the tumour of our model is smaller than the tumour of Chaplain and Lolas
model, in additional to the degrading of ECM of our model is less than the degrading of
Chaplain and Lolas Model. This means that the existence of the effector cells bounded
the growth of the tumour cells, and therefore reduces the degradation of ECM.
Figure 7.4 also shows that the effect of the effector cells is to reduce the size of the
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Figure 7.4: Plots showing the distribution of tumour cell density, effector cell density,
and ECM within the tissue at times corresponding to 35, 55, 60, and 70 respectively.
The red lines represent the ECM, the blue lines represent the tumour, and the black
lines represent the effector cell, the dash line represents the results of Chaplain and
Lolas (2005), the solid line represents the model (7.1).
tumour compared to the invasion model of Chaplain and Lolas. We note that the ECM
is still degraded but at a lower rate than the Chaplain and Lolas model.
Figure 7.5 shows the tumour cluster of Chaplain and Lolas model is increased and
greater than the tumour clusters of our model.
In figure 7.6 more clusters are appeared in Chaplain and Lolas model and bigger ef-
fector cell and ECM of our model. And the same behaviour in figure 7.7 and 7.8.
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Figure 7.5: Plots showing the distribution of tumour cell density, effector cell density,
and ECM within the tissue at times corresponding to 90, 105, 125, and 150 respec-
tively. The red lines represent the ECM, the blue lines represent the tumour, and the
black lines represent the effector cell, the dash line represents the results of Chaplain
and Lolas (2005), the solid line represents the model (7.1).
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Figure 7.6: Plots showing the distribution of tumour cell density, effector cell density,
and ECM within the tissue at times corresponding to 165, 185, 225, and 250 respec-
tively. The red lines represent the ECM, the blue lines represent the tumour, and the
black lines represent the effector cell, the dash line represents the results of Chaplain
and Lolas (2005), the solid line represents the model (7.1).
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Figure 7.7: Plots showing the distribution of tumour cell density, effector cell density,
and ECM within the tissue at times corresponding to 280, 310, 330, and 350 respec-
tively. The red lines represent the ECM, the blue lines represent the tumour, and the
black lines represent the effector cell, the dash line represents the results of Chaplain
and Lolas (2005), the solid line represents the model (7.1).
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Figure 7.8: Plots showing the distribution of tumour cell density, effector cell density,
and ECM within the tissue at times corresponding to 380, 410, 450, and 500 respec-
tively. The red lines represent the ECM, the blue lines represent the tumour, and the
black lines represent the effector cell, the dash line represents the results of Chaplain
and Lolas (2005), the solid line represents the model (7.1).
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7.4 Linear Stability Analysis
The system (7.3) has trivial (all species are zero), semi-trivial (free tumour steady state
i.e. healthy steady state), and non-trivial steady states. All these steady states are
saddle, the semi steady states are ‘healthy’, i.e., only ECM or only effector sell, and
we don’t have full malignant steady state. The non-trivial steady state has complex
eigenvalues, four with negative real part, and two with positive real part. We consider
the ODE equations of tumour and effector cell
∂E
∂ t
= rE(1−E)− dEC
E+a
,
∂C
∂ t
= bC(1− hC
E+a
). (7.4)
The results of the numerical computations in this direction are present in figure 7.9,
we note there is limit cycle, and in figure 7.10 we note the oscillation behaviour of the
numerical solution of tumour and effector over time.
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Figure 7.9: Plot showing the orbit of the ODE system (7.4) with initial condition near
the non-trivial steady state, converging to the limit cycle.
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Figure 7.10: Plots showing the numerical solution of model (7.4) over time. The blue
line is effector cells and red line is tumour cells. There are regular oscillations in both
the tumour cell and effector cell numbers over time.
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7.5 Bifurcation Analysis
In this section, we show a numerical bifurcation of system (7.4) with respect to pa-
rameters h and a. The bifurcation diagrams presented here have been generated by
the numerical continuation routine AUTO that is implemented within the XPP pack-
age (Ermentrout, 2002). AUTO provides implementation of numerical algorithms for
tracking Hopf bifurcation and therefore, establishing the existence of limit cycle.
Figures 7.11, 7.12, and 7.13, shows the bifurcation diagram of tumour density versus
the parameters h and a, and effector density versus the parameter a. Figure 7.11shows
the Hopf bifurcation was detected at h= 1.766. The solid dote represent the maximum
and minimum values of the periodic solutions that emerge when h lies in a particular
interval. Figure 7.12 and 7.13, shows the Hopf bifurcation was detected at a= 0.2277.
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Figure 7.11: Bifurcation diagram of a tumour density versus parameter h.
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Figure 7.12: Bifurcation diagram of a tumour density versus parameter a.
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Figure 7.13: Bifurcation diagram of effector density versus parameter a.
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7.6 2D Simulations
In this section, we present computational simulation results of model (7.3) on a two-
dimensional square domain, with homogeneous and heterogeneous ECM. We consider
the rectangular domain: Ω = (0,2)2, with zero-flux boundary conditions. The sim-
ulations were performed using COMSOL Multiphysics which uses a finite element
approach to solve PDEs.
7.6.1 2D simulations with homogeneous ECM
We assume the initial condition for effector cell, tumour cell, ECM, uPA, PAI-1, and
plasmin given as:
E(x,y,0) = 1− exp(−100((x−1)2− (y−1)2)),
C(x,y,0) = exp(−100((x−1)2− (y−1)2)),
V (x,y,0) = 1− 1
2
exp(−100((x−1)2− (y−1)2)), (7.5)
U(x,y,0) =
1
2
exp(−100((x−1)2− (y−1)2)),
P(x,y,0) =
1
20
exp(−100((x−1)2− (y−1)2)),
M(x,y,0) = 0.
Following the 1-dimensional results, figures 7.14, 7.15, and 7.16 shows respectively,
the spatial distribution of effector cells, tumour cells, and ECM, with time 100, 200,
300, and 400 respectively.
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Figure 7.14: Plots showing the spatial distribution of effector cell density within the
tissue in a 2-dimensional spatial domain at time corresponding to 100, 200, 300, and
400, respectively (homogeneous ECM).
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Figure 7.15: Plots showing the spatial distribution of tumour cell density within the
tissue in a 2-dimensional spatial domain at time corresponding to 100, 200, 300, and
400, respectively (homogeneous ECM).
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Figure 7.16: Plots showing the spatial distribution of ECM density within the tissue
in a 2-dimensional spatial domain at time corresponding to 100, 200, 300, and 400,
respectively (homogeneous ECM).
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7.6.2 2D simulations with a heterogeneous ECM
We focus in this section to explore the numerical results of our model in 2D domain
with a heterogeneous ECM density environment. To this end, we use the initial data
for the effector, cancer, uPA, PAI-1, and plasmin as given in (7.5) and the ECM initial
condition as figure 7.17.
Figures 7.18, 7.19, and 7.20 shows respectively, the spatial distribution of effector
Figure 7.17: Heterogeneous ECM initial conditions.
cells, tumour cells, and ECM, with time 100, 200, 300, and 400 respectively. We note
the tumour with heterogeneous ECM is close to the tumour with homogeneous ECM,
with different behaviour.
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Figure 7.18: Plots showing the spatial distribution of effector cell density within the
tissue in a 2-dimensional spatial domain at time corresponding to 100, 200, 300, and
400, respectively. Heterogeneous ECM initial conditions 7.17.
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Figure 7.19: Plots showing the spatial distribution of tumour cell density within the
tissue in a 2-dimensional spatial domain at time corresponding to 100, 200, 300, and
400, respectively. Heterogeneous ECM initial conditions.
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Figure 7.20: Plots showing the spatial distribution of ECM density within the tissue
in a 2-dimensional spatial domain at time corresponding to 100, 200, 300, and 400,
respectively. Heterogeneous ECM initial conditions.
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7.7 Discussion and Conclusions
The work we have presented in this chapter has developed a mathematical model for
tumour invasion with an immune response using a continuum model in 1 and 2 space
dimensions. This model consists of a system of nonlinear partial differential equations
and examines the effector cell response the tumour invasion. This model consists of
effector cells, tumour cells, ECM, uPA, PAI-1, and plasmin. First, we set all spatial
components of the model to zero and considered only the reaction kinetics in order
to compare between the behaviour of our model and the original Chaplain and Lolas
model. The spatial homogeneous simulation showed the behaviour of solutions have
regular oscillations (figure 7.10), because there is a closed orbit (limit cycle figure 7.9).
This was also explained by using bifurcation analysis.
Figure ?? explained the Hopf bifurcation with respect to the parameters h and a. The
results from the one dimensional model simulation compared the results of the Chap-
lain and Lolas model (Chaplain and Lolas, 2005) with our model.
Second, we presented the computational results of the spatio-temporal model, and we
noted from these simulations that the tumour size of our model is smaller than the tu-
mour size of the Chaplain and Lolas model because the immune cells are interacting
with the tumour cells, and also the degradation of ECM is less than that in the Chaplain
and Lolas model. In addition, the number of tumour cell clusters in our model is less
than those in the Chaplain and Lolas model. Also we found the tumour clusters of the
mathematical model which was discussed in this chapter to have the same range than
the tumour clusters of the Chaplain and Lolas model.
We calculated the steady states of the mathematical model and showed the linear sta-
bility analysis of these steady states. The mathematical model had trivial, semi-trivial,
and non-trivial steady states. All these steady states are saddle, the semi steady states
are healthy, i.e., only ECM or only effector sell, and we dont have a fully malignant
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steady state. The non-trivial steady state has complex eigenvalues, four with negative
real part, and two with positive real part.
The bifurcation analysis was applied in this chapter to explain the Hopf bifurcation
with respect the parameters h and a. The bifurcation diagram shows the bifurcation
was detected at h= 1.766, and at a= 0.2277.
Following the one-dimensional spatial model, we solved the model (7.2) in two-dimensional
space, with homogeneous and hetrogeneous ECM.
Chapter 8
Controlling Cancer Growth through
Competition for Space
In this chapter, we consider a Lotka-Volterra-type competition model that consists
firstly of two cell types in competition for space: effector cells and tumour cells. We
then extend the model to also include the effect of competition for space with extracel-
lular matrix (ECM). The Lotka-Volterra competition model describes two populations
that affect each other in a negative fashion. This model assumes that each species in
the absence of the other grows logistically to some carrying capacity.
8.1 Mathematical Model
The model system we consider is:
∂E
∂ t
= DE∇2E+ f (E,T ),
∂T
∂ t
= DT∇2T +g(E,T ), (8.1)
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where E denotes the density of effector cells, T the density of tumour cells,
f (E,T ) = E(1−E−βT ), g(E,T ) = rT (1−T − γE)
and DE ,DT ,β ,γ, and r are positive constants. In this model we consider that f and g
satisfy the following conditions (cf. Alzahrani et al. (2010)):
1. f (0,T ) = 0 = g(E,0).
2. (8.1) has exactly two stable, uniform equilibria S− = (0,1) and S+ = (1,0) and
two unstable, uniform equilibria (0,0) and (Es,Ts).
3. fT (E,T )< 0, gE(E,T )< 0 for (E,T ) ∈ (0,1)2.
4. The non-trivial solution (E,T ) of g(E,T ) = 0 are given by E = Γ(T ) for a
monotonically decreasing function Γ. Setting Γ(1) = 0 and Γ(0) = Eˆ, where
0 < Eˆ < 1, Γ has an inverse Γˆ∈C1([0, Eˆ], [0,1]), which can be extended trivially
to a function γ ∈C0([0,1], [0,1]) where
γ(E) =
 γˆ, E ∈ [0, Eˆ],0, E ∈ (Eˆ,1].
Model (8.1) has four steady states:
(0,0), (1,0), (1,0), (
β −1
γβ −1 ,
γ−1
γβ −1).
The first steady state is unstable, the second steady state is stable if β > 1 and a saddle
if β < 1, the third steady state is stable if γ > 1, and a saddle if γ < 1. Finally, the
fourth steady state is stable if β ,γ < 1 and a saddle if β ,γ > 1. In this chapter, we
choose β ,γ > 1.
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8.2 Computational Simulation Results
In this section, we solve model (8.1) numerically by using MATLAB.
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Figure 8.1: Plots showing the distribution of tumour and effector cell density within the
tissue at times from 0 up to final time 30. These plots illustrate the (a) standing wave of
tumour and effector cell, and (b) wave speed. The blue lines represent the tumour cell
, and the red lines represent the effector cell. The parameters are: DE = DT = 0.001,
β = γ = 5, r=1.
Figure 8.1(a) shows the spatial distribution of tumour and effector cells within the
tissue at time from 0 to 30. We note that the solution of model (8.1) is a travelling
wave. These results show that the wave of effector cells stops the wave of tumour cells
when they meet. Also figure 8.1 (b) shows that the wave speed is positive before the
effector wave meets the tumour wave, and then it becomes zero after meeting. Figure
8.2 shows when β > γ , the travelling wave solution moves to the right and does not
stop, i.e. the tumour occupies the space (the positive sign of the speed of the invading
tumour cells refers to a tumour increasing, and the negative sign of the speed refers to
the decreasing of effector cells). Figure 8.3 shows when γ > β , the solution moves to
the left, i.e. the effector cells occupy the space. The positive sign of speed refers to the
increasing of effector cells, and the negative refers to the decreasing of tumour cells.
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Figure 8.2: Plots showing the distribution of tumour and effector cell density within the
tissue at times from 0 up to final time 30. These plots illustrate the (a) standing wave of
tumour and effector cell, and (b) wave speed. The blue lines represent the tumour cell
, and the red lines represent the effector cell. The parameters are: DE = DT = 0.001,
β = 7,γ = 5, r=1.
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0
0.2
0.4
0.6
0.8
1
1.2
(a)
0 5 10 15 20 25 30 35 40 45 50
ï0.01
0
0.01
0.02
0.03
0.04
0.05
(b)
Figure 8.3: Plots showing the distribution of tumour and effector cell density within the
tissue at times from 0 up to final time 30. These plots illustrate the (a) standing wave of
tumour and effector cell, and (b) wave speed. The blue lines represent the tumour cell
, and the red lines represent the effector cell. The parameters are: DE = DT = 0.001,
β = 5,γ = 7, r=1.
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If DE 6= DT , then to get the standing wave between the two species E and T we need
to change the relationship between β and γ . Suppose DE is fixed, and the system has
standing wave solutions by fixing γ and varying β : if DT << DE , then β = γ2, if
DT = DE , this is the case above (β = γ), and if DT >> DE , then β =
√γ (Alzahrani,
2011).
8.3 Tumour Mutation Model
We now suppose that the tumour cells will mutate into a new class of tumour cells, and
therefore model (8.1) becomes:
∂T1
∂ t
= DT1∇
2T1+ r1T1(1−T1−β2T2− γE)−λT1H(t− t∗),
∂T2
∂ t
= DT2∇
2T2+ r2T2(1−T2−β1T1− γE)+λT1H(t− t∗), (8.2)
∂E
∂ t
= DE∇2E+E(1−E−β1T1−β2T2),
where T1 denotes the the sub-population 1 of tumour cell, T2 the sub-population 2, H
is a Heaviside function, r2 > r1 and DT2 = DT1 . In the above model (8.2), we have
assumed that the cancer cells of sub-population 1 are converted into cancer cells of
sub-population 2 after time t = t∗. The difference between the two sub-populations is
the proliferation rates. Cells of sub-population 2 proliferate more rapidly than cells of
sub-population 1, i.e. r2 > r1.
We impose zero-flux boundary conditions and the initial conditions are:
T1(x,0) = exp(−100x2),
T2(x,0) = 0,
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E(x,0) =
 0, if 0≤ x< 0.3,1− exp(−100(x−0.3)2), if 0.3≤ x≤ 1.
Figure 8.4 (a) shows the results of a computational simulation of model (8.2) where
t < t∗. This means the cancer cells meet the effector cells but the mutation has not
occurred, i.e. before the standing wave happens. In figure 8.4 (b) the cancer cells of
sub-population 1 start to convert to those of sub-population 2, and the sub-population
2 start to invade the effector cells. In figure 8.4 (c) the sub-population 1 of cancer cells
becomes zero, i.e. all sub-population 1 is converted to sub-population 2. Finally, in
figure 8.4, the subpopulation 2 continues to occupy the tissue and is close to arriving
at the other edge.
8.4 The Mutation Model with ECM Included
In this section, we add an equation modelling the interactions of ECM to model (8.2),
and we get:
∂T1
∂ t
= DT1∇
2T1+ r1T1(1−T1−β2T2− γE−αV )−λT1H(t− t∗),
∂T2
∂ t
= DT2∇
2T2+ r2T2(1−T2−β1T1− γE−αV )+λT1H(t− t∗), (8.3)
∂E
∂ t
= DE∇2E+E(1−E−β1T1−β2T2−αV ),
∂V
∂ t
= µV (1−V −β1T1−β2T2− γE).
We find the numerical simulation of model (8.3) with two initial conditions as in figure
8.5, and we apply the standing wave into two ways, first by the effector cells, second
by the ECM, depending on the relationship between parameters α,β1,β2 and γ , such
as:
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Figure 8.4: Plots showing the distribution of tumour and effector cell density within
the tissue at times from 0 up to final time 300. These plots illustrate the standing wave
of tumour and effector cell at (a) t=0-100, (b)t=101-200, (c) t=201-300, and (d) t=301-
400. The blue lines represent the sub-population 1 of tumour cells, black line represent
the sub-population 2 of tumour cells, and the red lines represent the effector cell. The
parameters are: DE = DT1 = DT2 = 0.001, β1 = γ = 5, β2 = 7,r1 = 1, r2 = 2, λ = 0.3.
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If α < β1 = γ , then we get a behaviour similar to the behaviour of model (8.1) such
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Figure 8.5: Plots showing the initial conditions of tumour cells, effector cells and
ECM.
that the ECM tends to zero, and the standing wave appears between the effector cells
and tumour cells, then the mutation of cancer cells occurs and the more aggressive
phenotype starts to invade the effector cells. Figure 8.6 (a) shows this case with initial
8.5 (a).
If β1 =
√
α , and γ < α , then the effector cells tend to zero and the standing wave
happens between the tumour cells and ECM. In addition, the mutation of cancer cells
occurs and the new sub-population starts to invade the tissue. This phenotype is il-
lustrated in figure 8.6 (b) with initial condition 8.5(a). We apply the initial condition
8.5 (b) for the two cases above. Figure 8.7 (a) shows the case α < β1 = γ . We note
that the solution does not change from the initial conditions because there is standing
wave between the tumour cells and effector cells and between effector cells and ECM.
After the new sub-population appears, the tumour cells invade the effector cells until
these vanish. The tumour cells then invade the ECM. Figure 8.7 (b) shows the case
β1 =
√
α , and γ < α , where the standing wave happens between the effector cells and
tumour cells, but the effector cells invade the ECM from the other edge, therefore, the
ECM disappears and the new sub-population of tumour cells invades the effector cells.
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Figure 8.6: Plots showing the distribution of tumour and effector cell density within the
tissue at times from 0 up to final time 300. The blue lines represent the sub-population
1 of tumour cells, black line represent the sub-population 2 of tumour cells, red lines
represent the effector cell, and green line represent the ECM. The parameters are:
DE = DT1 = DT2 = 0.001,(a) β1 = γ = 2, α = 1.5, β2 = 2.5, r1 = 1, r2 = 2, λ = 0.3,
(b) β1 = γ = 2, α = 4, β2 = 2.5, r1 = 1, r2 = 2, λ = 0.3. The two figures with initial
condition 8.5 (a).
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Figure 8.7: Plots showing the distribution of tumour and effector cell density within the
tissue at times from 0 up to final time 300. The blue lines represent the sub-population
1 of tumour cells, black line represent the sub-population 2 of tumour cells, red lines
represent the effector cell, and green line represent the ECM. The parameters are:
DE = DT1 = DT2 = 0.001,(a) β1 = γ = 2, α = 1.5, β2 = 2.5, r1 = 1, r2 = 2, λ = 0.3,
(b) β1 = γ = 2, α = 4, β2 = 2.5, r1 = 1, r2 = 2, λ = 0.3. The two figures with initial
condition 8.5 (b).
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8.5 Mutation Model with ECM and Matrix Degrading
Enzyme
The last model we discuss in this chapter is
∂T1
∂ t
= DT1∇
2T1+ r1T1(1−T1−β2T2−αV )−λT1H(t− t∗),
∂T2
∂ t
= DT2∇
2T2+ r2T2(1−T2−β1T1−αV )+λT1H(t− t∗),
∂V
∂ t
= −ηVM+µV (1−V −β1T1−β2T2), (8.4)
∂M
∂ t
= DM∇2M+δT2−ωM,
where M is a matrix degrading enzyme (MDE) of the ECM, and H is the Heaviside
function. We impose zero-flux boundary conditions and the initial conditions are
T1(x,0) = exp(−100x2),
T2(x,0) = 0,
V (x,0) =
1
2
exp(−100x2),
M(x,0) = 0.
The numerical simulation of model (8.4) is illustrated in figure 8.8, where the degrad-
ing enzyme product depends on the sub-population 2 of tumour cells, i.e. there is no
degradation of ECM before the mutation of sub-population 1 of tumour cells to sub-
population 2 because the ECM stops the invasion. Similar to the previous results the
sub-population 2 of tumour cells invades the ECM and occupy the space.
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Figure 8.8: Plots showing the distribution of tumour and ECM density within the tissue
at times from 0 up to final time 300. The blue lines represent the sub-population 1 of
tumour cells, black line represent the sub-population 2 of tumour cells, red lines repre-
sent the degrading enzyme of ECM, and green line represent the ECM. The parameters
are: DT1 =DT2 = 0.001,(a) α = 4, β1 =
√
α , β2 = 2.5, r1 = 1, r2 = 2, λ = 0.3, η = 2,
ω = 0.5, µ = 1, δ = 0.15.
8.6 Discussion and Conclusion
The Lotka-Volterra model is a phenomenological (holistic) model. It describes the
possible effects of competition between two species (in terms of coexistence or com-
petitive exclusion).
The numerical simulations discussed in this chapter were essentially associated with
the initial model of two equations representing the effector cells and tumour cells, such
that there is a standing wave between these species. We note that the solution of the
mathematical model was a travelling wave and also had a standing wave solution (i.e.
the wave of effector cells stops the wave of tumour cells when they meet). This phe-
nomenon happened when the two diffusion coefficients are the same and β = γ , i.e.
the waves stop and do not go either to the right or left. Also we showed that when
β > γ , the travelling wave solution moved to the right and did not stop, i.e. the tumour
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occupied the space, and when γ > β , the solution moved to the left, i.e. the effector
occupied the space.
We calculated the wave speed to illustrate that the speed tended to zero when the two
waves met - the positive speed of tumour cells refers to an invading tumour, and the
negative sign of speed refers to the decreasing of effector cells. After that we modified
the model by adding the equation for a second cancer cells population T2, which is
the sub-population 2 of tumour cells. This was to reflect the fact that cancer is a pro-
gressive disease, and as such it becomes more malignant as the cancer cells undergo
successive mutations. We showed in this case how the new type of cancer cells start to
invade the effector cells after the failure of the first type.
The third model discussed in this chapter was arrived at by adding the ECM equation
to the second model, and it explained how the standing wave arose from two types of
equations - the first one contained diffusion, and the second one without diffusion. The
second case was satisfied by choosing β1 =
√
α , and this model was discussed with
two types of initial conditions as in figure 8.5.
If β1 =
√
α and γ < α , then the effector cells tend to zero and the standing wave
happens between tumour cells and ECM. In addition, the mutation of cancer cells is
satisfied and the new sub-population starts to invade the tissue. We note that the so-
lution does not changed from the initial condition because there is a standing wave
between the tumour cells and effector cells, and between the effector cells and ECM.
After the second cancer cell sub-population appears, the tumour invades the effector
cells until they vanish, and then then the cancer cells invade the ECM.
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In the other case when α < β1 = γ , the standing wave happens between the effector
cells and the tumour cells, but the effector cells invade the ECM from the other edge,
therefore, the ECM disappears and the new sub-population of tumour cells invades the
effector cells.
Finally, we formulated a mathematical model which contained the ECM with cancer
cells but also added an equation describing the effect of matrix degrading enzymes.
These enzyme depend on the sub-population 2 of cancer cells, i.e. the enzymes appear
after the mutation of sub-population 1 to sub-population 2.
Chapter 9
Conclusions and Future Directions
We conclude this thesis with a brief summary of the major points and some possible
avenues of future exploration. Of course, this is by no means exhaustive, and we refer
the reader to the appropriate chapters for a more detailed account.
9.1 General Conclusions
In the framework of this thesis we have examined spatio-temporal mathematical mod-
els describing the growth of a solid tumour in the presence of an immune system re-
sponse. In the first chapter, we focussed on the spatio-temporal response of cytotoxic
T-lymphocytes to tumour cells. We have developed and extended ideas originally for-
mulated by Matzavinos et al. (2004) by proposing a possible kinetic mechanism lead-
ing to tumour evasion from the immune control.
Our model is based on the key concept that a tumour cell which survives the formation
of a complex with a cytotoxic T-lymphocyte can develop, with a given probability, an
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increased probability of surviving further attacks by CTLs. We do not specify whether
this so-called increased resistance is genetic or epigenetic. Indeed, from a kinetic point
of view, this is immaterial. However, in order to experimentally validate the hypothe-
sis, this distinction would be of paramount relevance. In this work we have dealt with
the spatio-temporal interplay between tumours and a specific immune response from
CTLs. We chose this approach because of the experimental evidence on the relevance
of CTLs in determining tumour dormancy or the evasion of many important tumours
such as melanomas, ovarian carcinomas and colorectal carcinomas, where the presence
of infiltrating lymphocytes is a useful prognostic marker (Galon et al., 2006; Zitvogel
et al., 2006). However, tumour immunoevasion from dormancy is a multi-faceted phe-
nomenon. We stress here that by no means do we think that ours is an exhaustive
theoretical treatment of a such complex phenomenon.
We have built our model based on the tumour dormancy mathematical model of Matza-
vinos et al. (2004); Chaplain and Matzavinos (2006), where parameters were fitted
to experimental animal (mouse) data. However, embedding the proposed evolution-
ary mechanism in a more complex setting, where a more detailed description of both
adaptive and innate immunity is included, should lead to results qualitatively similar
to those here illustrated.
Our simulations suggest that the proposed mechanism is able to mimic various dynam-
ics of immunoevasion during the lifespan of a mouse. We have also highlighted the
differential spatiotemporal contributions to evasion due, respectively, to: i) a decrease
in the probability pi of being lethally hit; ii) a decrease in the probability, embedded in
k+i , that a tumour cell is recognized by a CTL. In particular, our model suggests that
a decrease in the parameters pi is needed to produce evasion, which does not occur in
the case where pi remains constant at its baseline level inferred from the experimental
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data. However, the role of the parameters k+i is important since it can greatly acceler-
ate the simulated process. Moreover, our computational simulations also showed that
the proposed mechanism can also deeply affect the spatial patterning of the tumour. In
particular, our model suggests that to have a uniform invasion profile for the tumour
cells necessitates also having a decrease in the recognition rate, embedded in the pa-
rameters k+i . These parameters also differentially shape the spatial distribution of the
various classes of tumour cells.
Concerning the possible chemorepulsion of CTLs, our computational simulation re-
sults showed that, in our biological settings, although it does not affect the spatiotem-
poral dynamics of the total number of tumour cells, it has a remarkable influence on the
spatio-temporal distribution of the different individual classes of tumour cells. Further
analysis is needed to ascertain if, with different parameters, the effect of this factor can
be different, and in order to understand the behaviour in the current setting.
As far as the key ‘immuno-evasion-related’ parameters such as θi, pi, and k+i are con-
cerned, we were not able to fit them with experimental data (apart, of course, from the
values for p0 and k+0 , from Matzavinos et al. (2004); Chaplain and Matzavinos (2006))
because in the literature, to the best of our knowledge, immuno-editing is only illus-
trated by means of qualitative clinical or molecular experimental findings. In particu-
lar, no immuno-evasion-related tumour growth data are available. Indeed, a complete
experimental kinetic study of the adaptive evasion from tumour dormancy allowing,
for example, the plotting of tumour growth curves would currently be very difficult to
undertake. Thus we hope that this theoretical work may contribute to triggering such
experimental investigations, which would allow us to validate our model.
From a theoretical point of view, our model, although detailed and focused on a very
specific aspect of immuno-oncology, and on some very specific mechanisms, is con-
ceptually in line with the general theories by Bellomo (Bellomo et al., 2004; Bellomo
177
and Delitala, 2008; Bellomo, 2010). Indeed, here also the changes of activities of cells
upon encounters between tumour cells and effectors cells of the immune system are
central in determining the dynamics of the system.
In this work we essentially were interested in the basic facts of the immune response
to tumours. However, a number of immunotherapies have been proposed and also the-
oretically investigated (see d’Onofrio (2005); Arciero et al. (2004); Kim et al. (2008)
and references therein). We believe that both the experimental results concerning im-
munoevasion of tumours and the theoretical findings we have proposed here might
have some implication of interest in clinics. More in general, we share the opinion of
Zitvogel et al. (2006), who stressed that recent progress in immuno-oncology have not
influenced the way anticancer therapies are conceived and applied in clinics.
The model that was proposed here has to be understood as a detailed model at the
level of the kinetics of the cellular populations of a possible mechanism that might
enable tumour cells to evade from the control of adaptive immunity. The various spe-
cific (and tumour-dependent) strategies deployed by those cells in order to reach their
aim, are phenomenologically described by means of the model of the dependence of
the various parameters on the classes of tumour cells, as well as in the macroscopic
modelling of the chemorepulsion. This is a first step in a research effort for a more
complete description of tumour cell immunoevasion, which will include the detailed
modelling of the biological mechanisms underlying those and other specific evasion
strategies. Thus, given the complex network of interplaying between inter-cellular and
intra-cellular signalling, and given the various temporal scales (from the rapid dynam-
ics of the intracellular pathways involved, to the relatively slow growth of a tumour, up
to the very slow onset of immunoevasion) as well as the spatial ones (from individual
cells to visible neoplasms), a more detailed model will have to be multiscale. This
will involve a wide array of computational tools, from those typical of computational
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biology and bioinformatics, to more classical analytical and numerical methods of sta-
tistical mechanics and mathematical physics.
The second chapter discussed in this thesis is a mathematical model of the interplay
between a tumour and both the innate and the cellular part of the adaptive immune sys-
tem. We have developed and extended the ideas originally formulated by Owen and
Sherratt (1997); Matzavinos et al. (2004); de Pillis et al. (2005).
In this first set of simulations, we set all the spatial components of the model to zero
and consider only the reaction kinetics, then we shows some spatio-temporal simu-
lations which explain the interplay between tumours and macrophages, natural killer
cells and cytotoxic T lymphocytes.
We observed that there is a slowly damped oscillation in the behaviour of the tumour,
natural killer and CTL cells. Also we note that the solution converges to the second
steady state where the tumour size is smaller than the second stable steady state (fourth
steady state).
Also we discussed in this chapter the effect of the initial conditions to the solution of
ODE system, since we have multi-stable system, we should take the initial condition
of the ODE system close to the steady state.
We found there is a oscillation when we take the initial conditions close to the fourth
steady state and the oscillation are continuous with time increasing. This behaviour
means that there is a closes orbit around the steady state (limit cycle).
The model which discussed in this chapter is sensitive to the initial condition, because
when we multiplied the initial condition by 0.999, the shape of solution is changed and
some some sort of transient chaos, but the solution going after that to the steady state.
Also we found from the linear stability analysis for the model. there is four positive
steady state s, two are stable and two are saddle. We changed the stability of this steady
states by changed the parameters q0 and δ4, where got two saddle positive steady states.
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and the limit cycle still appears.
In the second set of simulations, we found the solutions of model 6.16. Following
to the ODE simulations we considered two cases, depending on the parameter values
such that the first case in like table 6.1 and the second case is by changed two param-
eters q0 and δ4. In the first case the solution tended to the positive steady state, and
the solution of macrophage M0 is similar to the solution of M1. The behaviour of the
solution of natural killer is similar to the behaviour of the solution for the tumour cells
up to time 400 days, then the shape of the profile of the natural killer cells changed.
The solution of the En reach the steady state value after a short time. The solution of
CTL again have the same shape of tumour solution with different values.
In the second case we got the different behaviour of solution because there is limit cy-
cle and oscillation in the shapes of solution and also the values of variables are changed.
The third chapter developed a mathematical model for tumour invasion with immune
response using a continuum model in 1 and 2 space dimensions. This model consists
of a system of nonlinear partial differential equations and examines how the effector
cell response the tumour invasion. This model consists of effector cell, tumour cell,
ECM, uPA, PAI-1, and plasmin. First, we set all spatial components of the model to
zero and consider only the reaction kinetics in order to compare between the behaviour
of our model and the Chaplain and Lolas model. The spatial homogeneous simulation
showed the behaviour of solutions have regular oscillation, because there is a close
orbit (limit cycle), this is also explained by using the bifurcation analysis.The results
from the one dimensional model simulation comparing the results of Chaplain and Lo-
las (2005) with our model.
Second, we presented the computational results of spatio-temporal model, we noted
from this simulations the tumour size of our model is smaller than the tumour size of
Chaplain and Lolas model because there is an immune cell interacting with tumour
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cells, and also the degrading of ECM is less than the degrading of Chaplain and Lolas
model. In additional to the number of cluster of our model is less than the cluster of
Chaplain and Lolas model. Also we found the tumour clusters of the mathematical
model which discussed in this chapter are have the same range than the tumour clus-
ters of Chaplain and Lolas model.
We calculated the steady states of the mathematical model and showed the linear sta-
bility analysis of these steady states. The mathematical model had trivial, semi-trivial,
and non-trivial steady states. All these steady states are saddle, the semi steady states
are healthy, i.e., only ECM or only effector sell, and we dont have full malignant
steady state. The non-trivial steady state has complex eigenvalues, four with negative
real part, and two with positive real part.
The bifurcation analysis was applied in this chapter to explained the Hopf bifercation
with respect the parameters h and a. The bifurcation diagram shows the bifurcation
was detected at h= 1.766, and at a= 0.2277. Following to the one-dimensional space,
we solved the model in two-dimensional space, with homogeneous and hetrogeneous
ECM.
In the last chapter we formulated a mode where competition for space was the key fea-
ture. The Lotka-Volterra model is a phenomenological (holistic) model. It describes
the possible effects of competition between two species (in terms of coexistence or
competitive exclusion).
The numerical simulations discussed in this chapter were essentially associated with
the model of two equations represented the effector cells and tumour cells, such that
there is a standing wave between these species.
We note that the solutions of the mathematical model was a travelling wave and also
a standing wave (i.e. the wave of effector cells stops the wave of tumour cells when
they meet). This behaviour happened when the diffusion coefficients are the same and
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β = γ , i.e. the waves stop going either to the right or left. Also we showed when
β > γ , the travelling wave solution moved to the right and did not stop, i.e. the tumour
occupies the space, and when γ > β , the solution move to the left, i.e. the effector cells
occupy the space.
We calculated the wave speed to illustrate that the speed tended to zero when the two
waves met, the positive sign of the speed of tumour cells referring to an invading tu-
mour, and the negative sign of speed refers to the decreasing of effector cells. After
that we modified the model by adding an equation for a second sub-population of can-
cer cells T2. Since cancer is a progressive disease, it is becomes more malignant as the
cancer cells undergo successive mutations. We showed in this case how the new type
of cancer cells start to invade the effector cells after the failure of the first type.
The third model discussed in this chapter was formulated by adding the ECM equation
to the second model, and explained how the standing waves arose from two types of
equations - the first one contained diffusion, and the second one without diffusion. The
second case was satisfied by choosing β1 =
√
α . This model was discussed with two
types of initial conditions.
If β1 =
√
α and γ < α , then the effector cells tend to zero and the standing wave
happens between the tumour cells and ECM. In addition, the mutation of cancer cells
is satisfied and the new sub-population starts to invade the tissue. We note that the
solution does not change from the initial conditions because there is a standing wave
between tumour cells and effector cells and between effector cells and ECM. After
the new cancer sub-population appears, the tumour invades the effector cells until they
vanish, then the cancer cells invade the ECM.
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In the other case when α < β1 = γ , the standing wave happens between the effec-
tor cells and tumour cells, but the effector cells invade the ECM from the other edge.
Therefore, the ECM disappeared and the new sub-population of tumour cells invaded
the effector cells.
Finally, we presented a mathematical model containing the ECM with cancer cells,
and added the equation of matrix degrading enzymes. These enzymes depended on
the sub-population 2 of cancer cells, i.e. the enzymes are secreted after mutation of
sub-population 1 to the sub-population 2.
9.2 Future Directions
One further aspect of immunoevasion that we would like to investigate in the future is
to extend the ideas of chapter five to the model of Owen Sherratt (Owen and Sherratt,
1997, 1999) and include here the interplay with the innate immune system. Our idea
would be to describe the immunoevasion from the initial control of the macrophages.
The tumour cells would form a complex with the macrophages, acquire an advantage
and thus transit to a class of more resistant cells T1, ... etc. Also we may try to modify
the results in chapter six, for the innate and adaptive immune response with cancer.
As we have seen, uncontrolled proliferation and abnormal cell migration are two of the
main characteristics of tumour growth. The tumour cells change their phenotype due
to mutations that are acquired during cancer progression. Initially, mutations alter the
proliferation control of the cells which leads to uncontrolled cell division Hanahan and
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Weinberg (2000). Then the transformed cells form a neoplastic lesion and the tumour
can grow up to a size at which the diffusion-driven oxygen supply becomes insufficient
(hypoxia) to support further growth.
Experiments with cultures of glioma cells (Giese et al., 2003) have shown a relation-
ship between migratory and proliferative behaviour. Especially, cell motion and pro-
liferation are mutually exclusive processes and highly motile glioma cells tend to have
lower proliferation rates, i.e. cells proliferate only when they do not move (resting
phase). This phenomenon is known as the migration/proliferate dichotomy (or the ‘Go
or Grow’ mechanism) (Giese et al., 996a,b).
In the future, we would like to test the idea of standing waves which was discussed in
chapter eight to the stationary mobile model with a switch between them (Lewis and
Schmitz, 1996).
The mathematical model would be represented in this case by a system of PDEs of the
form:
∂ts= rs(1− sk )+λmsm−λsms,
∂tm= D
∂ 2m
∂x2
−µm−λmsm+λsms,
where s(x, t) is the density of cells in the stationary state and m(x, t) is the density of
cells in the mobile state, λsm is the rate of switching from stationary to mobile state
and λms is the rate of switching from a mobile to stationary state.
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